TSS:Rfhg 119875.1

Basic information about the TSS

---

TSS ID: rfhg_119875.1 TSS ID(Version3): hg_243135.1 Species: human Chr: chr9		Start: 128683417 End: 128683429 Strand: +
Source datasets	ENCODE|PRJDB5282|PRJNA4843412|PRJNA548673|PRJNA615891 |DRA013844
Protocol	CAGE|C1CAGE|NETCAGE|ReCappable-seq|SLIC_CAGE|TIF-seq2
TSS cluster detected*	7

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4243023,EH38E2729765)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000454747.1:0 GeneID: 6418 HGNC/MGI_ID: HGNC:10760 UniProt_ID: B2REB7 Nearer transcript ids and distances: ENST00000372692.8:226 NM_001122821.2:364 AK300794:367 D45198:448 AB464200:466 AM393022:466 JF729356:467 view more...

Gene_name: SET nuclear proto-oncogene Gene_symbol: SET Gene_synonyms: 2PP2A IGAAD IPP2A2 PHAPII TAF-I TAF-IBETA Gene_source: HGNC:10760

TATA-Box annotation

---

Distance to TSS:	-370
Nearest PromoterID:	NM_001122821
Entrez ID:	6418
Nearest Unigene:	Hs.436687
Nearest Refseq:	NM_003011
Nearest Ensembl:	ENSG00000119335
Gene Name:	SET nuclear proto-oncogene
Gene Alias:	2PP2A|I2PP2A|IGAAD|IPP2A2|MRD58|PHAPII|TAF-I|TAF-IBETA
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.461538
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SET p2@SET p3@SET p4@SET p5@SET p6@SET p7@SET p8@SET p9@SET p10@SET
Sample		p1@SET	p2@SET	p3@SET	p4@SET	p5@SET	p6@SET	p7@SET	p8@SET	p9@SET	p10@SET
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	391.55	15.00	8.77	4.29	10.13	1.17	0.39	0.19	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	380.36	15.78	10.12	4.65	8.50	2.63	0.40	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	380.21	15.63	12.35	3.67	8.68	2.12	1.35	0.19	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	299.18	8.94	11.44	3.95	9.36	1.25	1.04	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	315.18	10.35	9.67	3.82	7.87	2.70	0.67	0.22	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	309.71	9.88	8.53	4.07	7.17	2.33	0.58	0.39	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	349.70	10.24	13.94	4.58	7.41	3.92	1.31	0.22	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	356.55	12.35	12.84	4.36	7.51	2.66	1.45	0.24	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	343.02	13.46	13.89	4.06	5.98	3.42	0.43	0.21	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	238.23	5.22	10.43	0.00	22.03	1.74	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	193.22	5.26	6.87	1.62	17.79	1.21	0.00	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	225.23	4.88	4.07	1.22	12.20	0.81	1.22	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	306.91	7.90	2.74	1.29	11.93	2.26	1.61	1.77	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	252.89	6.01	1.50	0.30	8.42	3.01	1.95	1.05	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	280.37	8.78	1.76	1.32	7.46	3.95	1.54	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	246.21	6.79	2.77	1.26	8.05	3.02	0.75	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	224.30	3.49	3.49	0.44	7.43	1.97	2.18	0.66	0.22	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	228.62	5.48	2.11	0.42	8.86	2.53	3.80	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	211.66	5.86	1.60	2.13	7.46	3.20	2.13	0.53	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	276.06	7.07	1.65	0.90	12.34	2.41	1.96	2.86	0.15	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	290.96	7.22	2.54	0.40	9.36	4.14	2.27	0.40	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	275.16	6.21	1.38	1.21	10.53	3.28	2.24	0.69	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	247.91	4.52	2.97	0.52	9.05	2.07	1.68	0.78	0.39	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	245.34	7.28	3.15	0.49	9.22	3.15	1.70	2.18	0.24	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	248.70	8.00	2.06	1.03	11.87	3.35	1.81	1.29	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	264.29	7.91	2.85	1.27	9.18	3.17	3.48	0.95	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	236.82	4.95	1.65	2.20	13.19	4.95	3.30	0.55	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	293.75	7.78	2.59	1.65	7.07	3.06	2.83	0.24	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	271.68	5.49	2.26	0.81	9.85	2.91	2.58	1.62	0.00	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	257.15	7.06	2.90	1.63	7.96	2.53	1.99	0.54	0.18	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	233.42	6.28	1.26	0.63	9.42	3.35	2.72	0.21	0.42	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	229.18	6.64	1.56	0.39	10.36	1.76	2.74	1.17	0.20	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	266.95	7.60	1.90	0.42	9.92	3.17	2.53	0.63	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	245.10	5.77	2.14	0.82	7.59	2.80	1.98	0.99	0.33	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	243.27	8.98	0.93	0.93	8.41	2.06	1.87	0.75	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	274.60	6.90	1.72	0.96	8.24	1.72	2.11	0.77	0.19	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	254.45	7.97	2.66	0.61	5.72	2.45	2.25	1.23	0.20	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	213.17	6.04	2.22	0.20	6.25	2.22	3.02	1.21	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	246.06	10.26	2.97	0.00	6.48	2.16	1.35	1.08	0.00	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	251.58	7.68	2.16	0.72	7.44	3.84	1.20	0.96	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	221.14	8.23	0.94	1.41	6.59	2.35	3.06	1.18	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	233.94	8.78	2.20	1.02	6.88	2.78	2.20	1.17	0.15	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	221.02	7.38	1.90	1.05	8.22	2.32	1.48	0.63	0.21	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	261.72	9.09	1.40	1.05	8.39	3.32	1.75	0.17	0.00	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	264.82	8.23	3.01	1.41	9.44	4.02	3.81	0.40	0.20	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	255.21	9.07	4.65	0.47	8.38	3.49	2.56	0.23	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	238.95	9.12	1.20	0.96	8.64	1.68	1.92	0.48	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	267.05	11.92	2.98	1.19	7.45	2.38	2.09	0.30	0.30	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	230.28	9.10	1.68	0.96	7.90	1.91	4.55	0.00	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	225.25	7.48	1.01	1.62	7.89	2.63	3.64	0.20	0.61	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	159.86	4.51	2.05	1.84	5.33	2.46	3.48	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	163.22	6.23	1.78	0.22	4.23	2.00	2.00	0.00	0.22	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	825.54	13.99	0.00	27.98	69.96	0.00	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	134.49	2.48	0.71	0.71	4.26	1.42	2.48	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	124.27	4.97	1.33	0.00	3.65	1.66	2.65	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	230.71	10.07	3.36	4.19	4.19	5.87	18.46	1.68	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	159.36	5.97	2.30	1.38	5.97	2.76	6.43	0.00	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	86.86	2.59	0.65	0.32	4.54	1.62	3.89	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	86.72	2.89	0.32	0.32	3.53	1.28	2.89	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	140.19	6.29	3.46	0.94	7.86	0.63	5.66	0.63	0.63	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	108.58	2.82	1.41	0.71	0.71	0.00	5.64	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	103.75	3.36	0.56	0.00	3.36	0.00	5.61	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	222.12	9.55	0.80	3.18	7.96	7.96	24.68	0.00	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	129.11	3.40	3.74	1.36	3.74	0.68	7.47	0.00	0.68	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	87.08	1.95	0.97	0.00	4.87	0.97	6.17	0.00	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	82.36	1.42	1.06	0.35	2.13	0.00	3.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	937.51	64.66	16.16	32.33	16.16	16.16	113.15	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	852.93	55.28	7.90	23.69	23.69	0.00	94.77	7.90	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	102.87	3.41	1.46	0.49	1.95	2.44	4.88	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	141.32	3.47	1.98	0.50	1.49	0.50	3.47	0.00	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	116.81	0.47	1.41	0.47	3.75	0.47	7.04	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	116.58	3.97	0.66	1.32	3.64	0.66	6.62	0.00	0.33	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	90.64	0.62	0.62	0.00	2.47	0.62	2.78	0.00	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	111.90	2.45	0.31	0.31	0.92	0.00	5.50	0.00	0.00	1.22
Adipocyte - breast, donor1	11376-118A8	90.75	2.85	4.28	0.95	0.79	1.58	0.95	0.48	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	127.22	5.29	2.41	1.12	1.12	0.32	1.12	1.60	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	110.05	2.93	3.18	0.64	1.40	1.78	1.15	0.25	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	97.17	2.99	2.24	0.75	0.00	0.00	2.24	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	88.75	3.68	1.00	0.67	1.00	1.34	1.34	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	91.23	1.91	2.55	0.00	0.64	0.64	0.64	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	65.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	149.94	6.32	0.45	0.00	0.45	0.45	1.81	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	99.92	2.26	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	282.80	5.87	1.37	0.59	3.52	1.37	1.96	0.78	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	225.72	6.18	0.77	0.26	2.06	1.29	0.77	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	248.67	5.58	0.56	0.28	2.51	0.28	0.84	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	281.56	5.29	0.59	0.00	2.94	0.00	2.94	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	229.48	7.72	0.56	0.24	0.56	0.16	1.77	0.16	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	183.32	5.81	0.65	0.00	1.94	0.65	1.94	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	142.89	2.13	0.00	0.00	0.53	0.53	2.67	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	148.01	3.34	0.00	0.56	1.11	0.00	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	112.29	2.91	0.00	0.00	0.83	0.42	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	118.80	2.51	0.25	0.00	0.25	0.50	1.51	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	113.55	2.62	0.00	0.00	0.98	0.00	0.33	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	121.18	3.65	0.30	0.30	0.30	0.00	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	227.63	4.86	2.43	1.33	0.44	0.00	0.88	0.66	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	58.09	1.08	2.15	0.00	0.00	0.36	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	39.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	203.47	6.12	1.80	2.52	1.08	0.72	0.72	1.08	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	98.74	3.35	1.67	0.00	1.67	0.00	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	131.49	2.88	1.23	0.21	1.44	0.21	0.21	1.23	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	194.98	1.72	2.40	0.57	3.43	4.46	1.26	1.03	0.57	0.69
Anulus Pulposus Cell, donor2	11463-119B5	176.82	4.65	4.41	0.24	1.47	1.47	0.73	1.71	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	95.25	0.90	0.00	0.00	1.35	0.00	1.35	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	124.60	5.21	1.30	0.43	1.30	0.43	1.30	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	0.00	0.00	0.00	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	114.19	2.99	0.30	0.30	0.60	0.30	1.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	123.94	2.53	0.00	1.26	1.26	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	64.03	0.66	0.00	0.66	1.98	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	100.71	1.62	0.00	0.00	1.95	0.32	0.65	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	123.30	2.43	0.49	1.94	2.91	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	65.33	2.97	0.59	0.59	0.59	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	114.87	5.65	0.38	1.13	1.13	0.75	1.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	115.38	5.08	0.73	0.73	0.73	0.00	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	60.18	1.25	0.00	0.00	3.76	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	103.95	3.13	0.33	0.49	1.32	0.16	0.99	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	98.27	0.00	0.00	0.00	1.36	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	64.39	1.36	0.45	0.30	2.87	0.60	0.75	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	114.12	1.61	0.00	0.00	1.61	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	126.02	2.83	0.38	0.57	1.13	0.94	1.13	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	90.34	2.14	0.53	0.80	2.67	0.27	1.34	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	94.62	3.90	0.98	0.00	0.98	0.00	2.93	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	126.55	3.98	0.83	0.33	1.33	0.83	0.83	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	64.84	0.00	0.00	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	141.61	0.00	0.00	0.00	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	127.10	3.09	1.03	0.86	1.37	0.51	1.03	0.34	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	0.00	0.00	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	119.41	4.85	0.97	0.49	0.97	0.00	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	131.67	4.17	0.38	0.00	1.90	0.00	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	49.67	1.21	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	103.75	3.42	0.00	0.57	1.71	1.71	1.71	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	116.72	2.14	0.86	0.21	1.28	0.64	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	74.07	0.52	0.52	0.26	1.29	0.26	1.29	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	112.61	2.35	0.00	0.00	0.94	1.41	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	132.16	1.29	0.96	0.32	1.29	0.32	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	58.50	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	100.61	4.68	0.58	0.00	0.58	0.58	1.17	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	103.27	4.22	1.20	1.20	0.90	0.60	0.30	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	77.22	1.19	0.00	1.19	1.19	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	113.92	3.05	0.51	1.53	1.02	1.53	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	108.24	3.06	0.51	0.25	1.27	0.51	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	64.81	1.91	0.00	1.27	1.91	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	106.16	2.59	0.86	0.00	0.86	0.00	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	111.14	2.33	0.21	0.42	0.85	0.42	1.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.13	0.87	0.29	0.00	2.90	0.00	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	126.59	3.78	0.94	0.00	0.94	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	116.46	3.39	0.34	0.51	1.70	0.17	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	90.34	0.00	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	101.40	2.11	0.00	0.00	4.23	2.11	6.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	116.85	3.00	1.07	0.21	1.93	0.21	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	60.17	0.60	0.60	0.60	3.01	0.00	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	110.08	2.19	0.00	0.00	2.19	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	117.24	2.53	1.38	0.46	2.76	1.15	0.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	5.10	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	71.69	1.02	1.02	0.76	2.80	1.27	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	131.91	5.16	0.62	0.62	0.83	0.41	1.24	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	72.22	2.45	0.31	0.92	1.84	0.00	0.61	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	127.63	3.82	0.00	0.48	2.87	0.48	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	105.99	3.10	0.22	0.44	1.77	0.89	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	70.19	1.53	0.00	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	108.56	0.55	0.55	1.11	1.11	0.55	1.11	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	114.66	2.91	0.00	0.26	1.06	0.26	1.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	62.88	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	295.74	6.26	2.95	0.37	1.72	4.30	0.61	0.00	0.61	0.00
Astrocyte - cerebellum, donor2	11580-120F5	190.16	4.62	1.20	0.17	1.88	2.23	0.51	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	89.56	1.05	1.05	0.00	1.26	1.05	0.00	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	352.77	6.27	8.71	1.39	7.67	4.53	0.00	0.00	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	514.28	10.84	7.44	1.46	5.01	3.88	1.46	0.00	0.65	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	469.56	9.10	4.77	2.09	5.22	3.13	0.60	0.00	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	692.36	16.51	7.68	9.40	5.62	4.01	14.79	0.34	0.57	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	777.37	20.42	13.28	11.02	5.14	3.88	19.17	0.13	0.88	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	692.34	13.09	12.97	9.22	5.01	4.67	16.05	0.23	1.14	0.80
Basophils, donor1	12241-129G9	180.98	5.75	0.00	0.26	0.26	0.26	6.80	0.00	0.00	0.00
Basophils, donor2	12242-129H1	259.05	13.71	0.36	0.36	1.08	0.00	10.46	0.36	0.00	0.36
Basophils, donor3	12243-129H2	180.95	5.14	0.15	1.47	0.73	0.88	18.67	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	83.22	1.29	1.51	0.00	0.22	0.22	0.22	1.72	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	37.03	0.91	0.46	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	186.51	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	112.35	5.02	8.79	5.02	0.63	3.77	0.63	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	100.02	5.20	5.82	2.08	0.00	0.62	0.62	2.91	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	101.79	2.53	2.53	0.92	0.23	0.46	1.38	2.07	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	227.45	2.16	5.04	2.52	0.18	1.26	1.08	1.98	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	493.02	7.42	6.60	21.64	3.71	3.30	15.77	0.21	1.65	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	529.62	8.15	13.04	24.22	3.96	3.73	12.34	0.00	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	446.09	10.55	0.32	1.92	5.12	2.88	15.67	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	765.30	0.00	0.00	0.00	0.00	0.00	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	133.00	3.38	0.00	0.56	0.00	0.00	10.14	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	158.32	4.27	0.00	0.37	0.56	0.00	12.81	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	152.80	5.05	0.22	0.44	0.22	0.22	13.17	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	82.37	0.85	0.85	0.57	0.00	0.57	17.83	0.00	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	125.47	1.14	0.00	1.52	0.00	0.00	12.51	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	126.57	2.30	0.00	1.64	0.33	0.66	19.40	0.00	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	102.92	2.46	0.29	0.43	0.14	0.14	10.41	0.00	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	129.45	1.21	0.60	0.60	0.00	0.30	12.37	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	144.98	1.66	0.24	1.18	0.24	0.00	8.53	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	65.62	2.01	0.17	0.33	0.00	0.00	5.52	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	95.50	2.21	0.28	0.83	0.00	0.00	7.45	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	88.76	2.23	0.25	0.50	0.25	0.50	8.43	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	54.43	0.98	0.20	0.20	0.20	0.00	9.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	65.88	1.25	0.00	0.53	0.00	0.00	8.19	0.00	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	67.90	0.65	0.65	0.22	0.00	0.44	12.62	0.00	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	62.98	0.23	0.00	0.23	0.00	0.23	6.56	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	108.77	2.11	0.00	0.00	1.06	0.00	17.42	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	85.42	1.11	0.00	0.00	0.00	0.00	17.75	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	78.09	1.34	0.00	0.89	0.00	0.00	9.07	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	87.40	3.19	0.00	0.20	0.60	0.20	8.78	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	84.32	1.25	0.62	1.25	0.00	0.00	12.28	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	54.45	1.60	0.23	0.46	0.00	0.00	8.24	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	70.80	1.58	0.00	0.00	0.45	0.00	9.50	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	61.54	0.87	0.00	0.00	0.00	0.00	8.73	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	74.78	0.81	0.27	0.81	0.81	0.54	6.99	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	89.32	1.22	0.70	0.87	0.00	0.35	13.43	0.00	0.00	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	94.26	1.26	1.26	0.00	0.00	0.00	10.94	0.00	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	49.23	1.10	0.00	0.18	0.18	0.00	6.25	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	87.71	1.41	0.00	0.35	0.70	0.35	10.22	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	76.34	0.88	0.88	0.44	0.44	0.44	6.14	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	70.80	1.22	0.00	0.17	0.35	0.35	8.72	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	86.23	0.74	0.74	1.12	0.00	0.37	10.41	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	86.44	1.29	0.22	1.29	0.22	0.22	18.11	0.00	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	41.36	0.00	0.82	0.00	1.23	0.00	3.69	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	76.26	0.93	0.00	0.23	0.23	0.23	8.81	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	49.88	0.93	0.00	0.46	0.46	0.23	12.06	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	110.94	1.31	0.22	1.31	0.00	0.00	25.28	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	108.80	1.62	0.92	1.39	0.00	0.46	27.49	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	113.29	0.22	0.00	1.08	0.22	0.22	24.69	0.00	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	122.71	2.34	0.00	1.09	0.16	0.16	28.81	0.00	0.00	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	110.55	1.22	0.00	0.70	0.17	0.17	23.93	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	235.90	2.90	0.89	0.89	0.45	0.45	39.69	0.00	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	86.76	1.79	0.00	1.02	0.26	0.00	9.95	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	99.02	1.54	0.00	0.22	0.00	0.00	17.13	0.00	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	113.06	1.89	0.00	0.42	0.00	0.00	17.90	0.00	0.00	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	270.30	2.03	0.00	0.00	6.10	2.03	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	280.01	4.07	0.68	2.71	0.00	0.00	13.56	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	289.97	5.18	1.04	1.04	0.00	0.00	10.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	330.48	9.06	0.53	1.07	1.07	0.00	10.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	347.37	6.43	1.07	1.61	3.22	0.54	8.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	281.48	4.21	0.70	0.00	0.70	0.00	4.91	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	263.54	6.27	2.35	3.14	0.78	0.00	7.84	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	304.52	7.91	0.00	3.95	3.95	0.00	14.50	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	352.60	10.68	1.64	3.29	1.64	0.82	18.90	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	275.66	10.88	0.73	1.45	1.45	0.00	14.51	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	274.12	6.06	1.01	2.02	2.02	0.50	12.62	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	420.22	13.74	0.00	0.00	1.21	0.00	2.02	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	279.24	8.39	0.00	0.00	0.40	0.00	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	220.89	6.02	0.00	1.00	5.02	1.00	6.02	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	251.69	6.74	0.00	0.00	2.81	1.12	9.55	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	532.07	10.90	1.50	1.50	4.51	3.76	15.78	0.00	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	482.08	13.08	1.35	2.03	8.12	2.03	16.69	0.00	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	440.61	24.28	0.00	0.00	2.50	0.36	1.43	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	317.82	18.98	0.00	0.00	3.06	0.00	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	335.19	15.25	0.00	0.00	0.91	0.30	1.83	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	272.08	5.87	0.77	0.51	3.57	0.00	4.34	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	302.76	8.76	0.67	1.35	2.47	0.45	4.27	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	264.75	5.46	0.00	0.86	2.30	0.00	4.31	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	250.32	10.90	0.00	0.47	4.74	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	285.14	9.13	0.70	0.00	2.81	0.70	2.11	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	250.51	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	210.85	6.07	0.14	0.72	1.16	0.29	3.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	250.97	6.78	0.34	0.51	2.71	0.17	3.05	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	206.02	5.80	0.97	0.48	2.10	0.16	1.61	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	199.94	7.17	0.45	0.00	0.90	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	230.60	8.73	0.00	0.00	2.80	0.35	3.49	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	285.55	7.04	0.44	0.00	0.88	0.44	3.96	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	295.99	8.01	0.42	0.00	1.69	0.00	3.79	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	254.52	6.44	0.21	0.42	1.25	0.00	2.91	0.00	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	202.15	4.34	0.00	0.00	1.34	0.00	2.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	304.57	10.33	0.00	0.00	4.62	0.00	0.54	0.00	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	400.89	15.54	0.54	0.00	6.97	0.54	1.07	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	285.12	14.35	0.00	0.00	5.38	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	397.56	11.68	0.37	1.11	2.78	0.37	4.45	0.00	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	305.00	9.75	0.22	0.65	2.82	0.00	2.17	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	307.24	8.20	0.00	0.42	2.10	0.21	4.62	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	261.90	12.13	0.00	0.00	3.03	0.00	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	269.92	13.00	0.00	0.00	3.47	0.00	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	377.85	14.82	0.00	0.00	3.49	0.44	3.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	420.64	15.84	0.00	0.00	2.97	0.00	0.99	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	336.96	24.93	0.00	0.00	3.69	0.92	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	335.00	6.98	0.00	0.00	8.37	0.00	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	425.36	17.17	0.28	0.28	1.94	0.28	6.37	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	480.97	19.14	0.00	0.00	4.17	0.00	8.59	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	344.96	12.32	0.00	1.54	3.08	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	380.68	10.74	0.36	0.36	3.94	0.00	3.94	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	422.42	18.00	0.00	0.00	5.54	0.00	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	348.35	13.75	0.00	0.33	1.96	0.00	3.60	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	266.18	14.64	0.38	0.38	1.88	0.00	3.75	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	377.72	14.90	0.00	0.00	2.02	0.25	3.53	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	283.53	13.53	1.38	0.69	9.18	0.46	7.57	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	273.43	11.02	1.44	1.44	7.19	0.96	4.79	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	234.19	7.66	0.27	0.82	9.85	0.82	6.29	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	278.90	12.01	1.20	0.90	5.40	0.30	10.81	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	366.45	13.44	0.72	0.72	6.48	0.24	3.84	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	321.07	16.60	1.59	0.68	9.32	0.23	6.82	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	339.62	13.69	1.09	1.74	5.87	1.09	5.65	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	317.42	12.63	0.79	1.32	7.90	1.05	4.21	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	374.76	16.65	1.64	1.41	6.57	0.23	8.91	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	361.35	19.62	0.60	0.91	5.43	0.00	9.36	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	346.57	11.04	2.32	1.45	9.01	1.16	7.84	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	417.24	17.05	1.07	2.13	8.79	0.27	6.13	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	363.33	23.20	0.00	0.44	7.88	0.44	4.38	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	372.54	16.85	0.00	0.00	9.56	0.46	4.55	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	346.83	18.65	0.75	0.75	8.20	0.00	5.22	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	312.61	11.16	0.72	1.08	8.64	0.72	5.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	285.42	12.95	0.58	0.58	6.33	0.86	6.04	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	271.76	13.67	1.18	0.47	4.71	0.71	5.19	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	418.31	18.70	0.95	0.95	6.02	1.27	6.65	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	366.92	17.22	0.62	0.92	7.07	0.62	6.15	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	369.95	22.44	1.28	1.60	9.30	0.96	7.69	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	319.36	16.83	0.38	0.76	8.80	0.38	6.50	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	351.94	11.43	0.39	0.79	5.91	0.79	7.09	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	312.40	7.56	0.76	0.00	9.08	0.00	5.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	311.55	14.45	0.00	0.80	34.53	0.00	4.82	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	349.01	9.79	0.00	1.40	29.38	0.00	1.40	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	407.71	11.02	0.00	1.00	31.05	0.00	2.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	442.31	14.62	12.79	1.83	3.66	0.00	1.83	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	199.12	8.89	2.96	0.00	1.98	1.98	0.99	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	241.40	5.47	4.63	1.26	0.74	3.05	1.47	2.00	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	168.83	11.79	2.08	0.69	1.73	1.73	1.73	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	134.69	5.33	1.07	0.00	0.71	0.71	0.36	0.36	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	164.75	3.98	1.02	1.02	2.05	1.14	0.68	0.80	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	397.49	17.91	2.69	0.00	1.79	1.79	2.69	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	132.24	2.83	0.00	0.81	0.40	0.00	3.24	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	394.08	8.72	25.82	4.13	4.48	16.07	1.38	0.34	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	313.38	5.34	16.89	2.99	3.42	11.97	0.43	0.64	1.07	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	342.49	9.03	21.06	4.60	4.87	11.33	1.42	0.88	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	206.05	5.32	0.92	0.55	1.10	0.83	1.56	0.18	0.00	0.09
Corneal Epithelial Cells, donor1	11526-119I5	77.07	0.66	0.44	0.88	0.22	0.22	0.00	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	56.88	3.41	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	97.40	3.07	3.32	1.02	0.26	0.77	0.77	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	173.02	6.27	0.99	0.50	0.33	0.17	3.96	0.00	0.00	2.31
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	174.11	9.15	1.26	0.95	0.00	0.00	6.62	0.00	0.32	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	106.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	110.91	4.54	0.43	0.76	0.22	0.22	4.86	0.22	0.11	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	236.42	8.54	2.05	3.42	0.68	0.34	11.62	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	254.62	9.79	1.31	2.61	1.31	1.31	11.75	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	269.07	10.16	1.94	1.94	1.45	1.94	13.55	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	283.17	7.84	1.50	0.17	1.00	1.67	4.84	0.33	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	183.66	2.93	0.00	0.00	1.76	0.59	1.17	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	371.60	7.64	0.85	0.57	2.26	1.13	2.55	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	228.05	5.90	1.57	0.79	1.57	0.39	1.57	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	181.51	5.82	0.00	0.29	1.16	0.58	0.87	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	312.21	8.23	2.82	1.88	1.88	0.71	4.24	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	204.59	5.79	1.40	1.05	1.75	0.53	3.68	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	170.01	2.44	1.77	0.00	4.21	0.66	3.99	0.44	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	196.86	5.78	1.52	0.30	2.43	1.22	4.56	0.61	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	221.58	4.79	1.13	0.56	3.95	0.28	1.41	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	150.35	5.05	0.59	0.30	1.19	0.30	1.78	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	119.23	3.12	1.04	0.52	1.56	0.52	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	138.10	3.83	0.00	0.00	1.84	0.43	1.56	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	392.92	14.40	0.40	0.00	3.60	0.80	0.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	132.08	4.19	0.52	0.00	2.10	1.05	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	484.31	10.19	5.34	2.24	3.60	4.22	9.69	0.37	1.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	462.77	10.21	3.26	1.74	1.96	3.04	6.74	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	574.61	13.43	6.72	1.59	2.20	3.18	7.57	0.37	0.49	0.00
Endothelial Cells - Vein, donor1	11267-116G7	203.61	4.55	1.14	1.14	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	212.34	4.19	1.40	0.00	1.40	0.70	3.49	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	293.13	6.91	0.47	0.31	3.30	0.94	2.83	0.16	0.31	0.00
Eosinophils, donor1	12244-129H3	640.37	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	434.02	9.90	0.00	0.00	0.00	0.00	3.30	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	324.58	10.70	0.00	0.00	0.00	0.00	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	74.52	1.95	1.95	0.73	0.73	0.73	0.73	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	0.00	2.08	0.00	0.00	0.00	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	0.00	0.00	0.00	0.00	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	121.51	3.69	0.82	0.82	0.82	1.23	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	55.07	1.75	1.09	1.09	0.44	0.99	1.53	0.44	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	132.82	4.33	1.73	1.19	0.76	1.84	2.38	0.00	0.11	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	212.48	4.49	4.12	1.09	1.46	1.82	2.67	0.00	0.49	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	81.88	2.32	2.32	1.36	8.87	1.23	1.23	0.41	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	170.86	5.17	3.90	0.95	1.79	1.05	2.43	0.84	0.11	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	133.85	4.48	1.05	1.05	8.43	1.05	2.11	0.53	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	292.00	10.30	1.66	1.99	3.99	1.66	2.33	0.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	197.78	7.26	3.18	0.91	0.91	0.00	1.36	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	151.59	3.03	1.52	0.00	3.79	0.00	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	131.38	6.47	1.10	0.16	0.63	0.79	0.63	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	301.29	7.58	3.03	0.30	2.42	3.03	3.33	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	225.25	6.47	2.79	0.51	4.31	1.14	2.92	0.89	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	253.62	9.55	1.97	0.30	2.12	1.36	3.03	0.61	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	202.59	4.96	4.29	0.13	1.34	5.23	1.07	0.13	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	194.14	6.47	6.90	1.29	0.86	5.61	0.86	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	361.80	10.25	5.86	1.46	0.00	4.39	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	302.83	4.38	0.46	0.23	1.38	0.23	0.92	0.46	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	203.02	4.24	3.22	1.53	3.56	3.56	1.87	0.17	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	219.76	9.86	1.88	1.17	1.88	0.47	3.05	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	258.48	5.66	1.42	0.47	1.42	1.42	1.89	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	234.16	5.92	1.09	0.48	2.18	1.21	2.66	0.24	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	393.51	8.03	1.36	0.34	2.15	1.24	2.49	0.23	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	390.08	11.86	3.49	0.87	1.74	2.27	3.84	0.00	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	462.42	11.37	3.74	1.79	1.30	2.11	2.44	0.32	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	276.74	4.79	1.87	1.67	1.87	1.87	2.92	0.42	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	261.74	9.69	5.24	3.41	0.79	3.14	3.67	0.79	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	324.45	5.67	3.16	0.79	2.77	1.32	2.37	0.13	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	346.91	6.57	1.35	0.58	3.38	1.16	2.03	0.29	0.39	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	228.56	10.39	2.08	1.04	2.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	192.94	4.05	0.70	0.18	1.41	1.59	1.23	0.18	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	330.34	9.51	3.90	0.94	2.65	1.87	2.81	0.00	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	255.31	7.30	0.81	1.35	1.62	1.49	2.30	0.00	0.14	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	278.77	10.23	1.06	1.06	2.12	0.00	1.41	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	231.94	5.26	1.90	1.17	1.46	2.05	2.92	0.00	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	254.16	7.50	3.27	2.73	1.09	1.09	2.73	0.00	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	417.27	14.15	4.39	2.08	2.30	2.63	2.85	0.00	0.55	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	208.08	5.14	1.47	0.29	5.28	1.17	1.91	0.00	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	103.31	0.00	4.08	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	422.28	8.95	0.00	0.00	0.00	2.98	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	325.42	5.70	1.48	1.90	1.27	1.69	1.90	1.06	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	219.92	7.50	0.00	0.00	0.00	0.83	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	144.06	2.80	0.00	0.00	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	40.58	0.00	0.00	0.00	0.84	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	387.70	10.56	2.44	0.00	0.41	1.22	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	119.83	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	214.43	0.00	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	360.21	5.43	3.49	0.39	2.33	0.97	2.52	0.00	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	583.82	10.31	2.58	1.21	3.79	2.43	3.34	0.15	0.76	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	479.48	16.22	2.14	1.22	2.75	1.53	3.67	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	354.15	8.40	1.14	1.14	0.38	1.14	1.14	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	179.27	4.05	1.08	1.62	0.81	0.54	1.35	0.00	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	220.00	4.18	1.16	0.93	1.51	0.58	0.70	0.00	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	232.45	7.63	3.09	0.44	1.11	2.21	2.65	0.22	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	239.76	7.11	1.22	0.20	1.02	0.41	0.41	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	140.32	2.00	0.00	0.00	0.00	0.67	2.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	197.68	1.98	1.98	0.79	0.40	1.19	2.37	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	211.35	5.36	1.19	0.60	5.56	0.20	1.19	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	171.76	4.09	0.89	0.18	1.24	0.71	1.07	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	227.24	3.94	0.99	0.20	0.99	1.18	1.77	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	178.71	6.92	1.50	0.90	5.11	0.00	1.20	0.30	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	277.98	9.28	2.16	1.08	1.73	1.30	2.37	0.22	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	137.17	3.80	1.52	0.51	2.78	0.76	1.52	0.51	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	186.06	3.45	0.82	1.31	1.64	0.98	2.13	0.00	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	165.42	5.81	2.21	2.81	7.22	0.80	2.01	0.00	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	231.36	7.03	1.91	0.60	1.21	1.51	1.31	0.20	0.20	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	179.53	3.02	1.81	0.60	1.51	1.51	3.32	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	194.36	3.98	0.91	0.17	3.07	0.91	1.82	0.17	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	229.59	4.79	1.71	0.68	3.42	1.03	1.88	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	137.94	4.60	1.31	0.66	2.96	0.99	1.31	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	236.58	5.75	2.45	1.28	0.75	0.75	1.07	0.11	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	275.79	7.93	2.02	1.52	1.52	0.84	2.19	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	113.07	4.23	3.61	0.94	0.31	1.25	2.04	0.47	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1240.95	44.32	0.00	0.00	0.00	22.16	66.48	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	144.67	4.36	0.00	3.49	5.23	0.00	5.23	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	103.32	2.95	9.53	6.59	0.17	0.87	2.25	2.25	0.00	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	147.04	4.42	6.77	5.20	0.52	0.78	2.34	1.82	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	176.05	8.94	19.93	7.41	0.51	2.04	2.04	1.28	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	395.02	8.42	23.73	33.68	6.89	3.83	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	396.88	10.85	21.69	42.75	6.38	7.02	3.83	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	504.92	12.84	62.47	100.70	3.99	14.26	2.85	0.29	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	528.08	8.55	7.17	15.17	11.31	4.69	0.83	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	423.32	9.36	12.33	18.72	12.33	5.25	0.68	0.23	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	468.38	14.86	32.89	49.93	5.35	7.93	2.18	0.20	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	455.45	3.70	9.52	14.27	9.52	2.38	1.59	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	488.89	10.76	7.18	13.37	17.61	1.96	1.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	336.97	8.84	41.13	53.51	8.40	7.08	0.88	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	524.16	9.61	30.10	24.59	7.63	7.07	1.70	0.14	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	508.21	9.61	21.92	16.87	7.39	4.68	0.74	0.62	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	480.84	7.25	29.01	29.55	5.10	5.10	0.54	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	482.69	10.53	13.26	8.30	5.95	5.58	2.60	0.12	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	468.57	7.89	21.73	10.52	5.68	6.92	1.11	0.14	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	370.01	5.29	25.82	23.38	5.29	8.34	1.83	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	352.76	6.85	13.01	7.30	4.34	5.93	1.37	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	360.49	5.36	20.43	12.46	5.73	6.85	1.99	0.25	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	393.44	7.65	26.88	14.64	5.03	8.31	0.66	0.87	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	424.01	7.98	6.21	3.55	4.14	3.55	2.07	0.89	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	438.09	10.01	13.67	6.36	6.99	4.77	0.48	0.32	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	376.46	5.14	16.31	7.15	2.90	2.01	0.89	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	435.93	6.86	6.45	2.42	7.06	4.44	2.42	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	507.06	10.35	8.99	5.43	5.94	4.92	1.53	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	416.58	9.67	16.67	9.84	4.79	4.61	1.95	0.35	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	444.22	8.32	4.47	2.19	8.64	4.27	3.02	0.10	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	486.71	8.88	7.17	3.42	8.54	3.76	3.93	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	428.89	9.18	7.41	3.98	6.86	4.65	2.10	0.44	0.00	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	381.95	8.49	10.57	4.24	5.07	4.58	1.91	0.25	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	423.27	9.39	10.62	3.47	5.31	4.49	3.47	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	417.15	8.25	5.57	2.48	6.40	4.75	1.44	0.21	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	445.72	6.46	5.30	2.31	6.92	4.84	2.65	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	369.55	9.01	4.67	3.17	6.34	3.84	2.50	0.17	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	301.33	4.41	4.19	3.31	5.07	3.75	1.98	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	396.90	5.41	4.18	3.44	9.22	5.04	3.44	0.25	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	385.62	8.59	5.19	3.24	5.02	4.05	2.59	0.49	0.16	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	322.64	3.21	4.49	3.21	9.62	3.53	1.92	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	344.81	6.25	3.98	2.65	4.55	2.94	3.41	0.00	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	305.44	5.54	2.69	1.27	3.01	2.21	3.32	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	308.34	3.95	5.47	1.52	4.56	2.13	5.47	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	325.95	8.57	4.08	1.46	6.17	3.14	1.78	0.10	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	268.95	3.95	2.85	1.32	6.15	2.85	2.20	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	271.85	5.05	4.77	1.12	5.33	2.81	2.24	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	306.37	7.59	1.94	2.31	6.48	2.31	2.59	0.19	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	215.79	8.02	4.81	1.60	2.14	2.94	1.34	0.00	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	300.96	9.79	3.06	1.53	3.98	1.68	2.91	0.46	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	253.63	8.68	2.33	1.30	3.76	2.07	3.11	0.39	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	248.30	7.05	3.80	1.08	5.69	2.44	4.61	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	251.82	3.69	3.87	1.47	7.37	3.32	2.77	0.37	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	230.28	4.82	2.41	0.88	5.70	1.32	1.75	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	337.19	11.90	8.93	0.00	3.97	1.98	2.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	242.45	6.99	2.77	0.53	3.96	2.24	1.85	0.13	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	212.25	5.04	1.61	0.20	2.62	0.20	1.82	0.20	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	269.92	5.34	1.27	0.76	2.03	1.52	2.03	0.25	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	601.76	10.95	42.20	26.47	4.98	4.98	2.39	0.00	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	581.33	11.25	36.05	34.36	6.63	5.85	3.85	0.15	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	713.18	14.32	40.71	46.24	11.05	5.52	2.45	0.00	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	301.66	5.63	23.78	37.86	5.95	3.13	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	296.68	7.06	22.32	39.84	2.83	3.39	1.98	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	406.32	10.15	33.21	22.14	3.69	0.46	1.38	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	465.26	12.37	24.75	24.75	2.47	2.47	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	612.71	18.95	39.45	29.78	5.03	4.25	1.93	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	585.63	14.44	51.34	24.07	8.02	9.63	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	438.18	6.96	24.34	22.60	5.22	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	551.69	16.92	47.52	17.58	4.56	8.14	0.98	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	595.88	11.12	33.36	21.83	7.00	9.06	2.88	0.00	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	406.54	16.66	36.65	16.66	3.33	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	530.49	12.86	38.87	9.79	3.92	11.19	0.56	0.00	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	506.28	12.09	47.39	17.65	4.90	9.48	0.65	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	394.25	9.23	25.17	11.74	7.55	12.58	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	566.49	8.27	32.44	8.59	7.00	13.36	0.64	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	494.21	11.89	48.23	13.25	3.40	8.15	0.34	0.34	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	354.98	8.35	20.88	10.44	2.09	8.35	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	650.01	9.74	21.76	6.87	8.02	10.88	0.57	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	388.03	6.81	15.10	6.22	2.37	10.95	0.89	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	384.57	5.08	22.02	11.86	3.39	13.55	1.69	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	629.18	14.50	34.79	12.01	3.73	9.94	0.83	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	620.89	16.57	27.62	11.05	5.75	9.21	0.92	0.69	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	316.11	0.00	15.81	5.27	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	456.30	10.76	20.76	3.46	6.15	6.54	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	399.31	7.82	24.12	5.87	3.26	7.82	0.33	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	317.03	3.34	14.71	3.34	0.67	8.03	0.00	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	576.75	4.62	12.71	1.93	5.39	7.71	1.16	0.77	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	615.87	14.04	13.01	4.11	5.82	7.19	1.03	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	320.54	2.48	7.45	4.97	2.48	2.48	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	393.05	3.77	13.68	2.83	6.13	11.80	0.47	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	435.12	6.03	10.26	1.81	3.02	6.64	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	392.19	5.09	11.19	7.12	5.60	10.17	0.51	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	486.98	7.18	12.76	2.79	7.18	7.98	1.99	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	469.18	8.88	7.40	1.48	5.92	4.44	0.99	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	315.18	3.54	11.80	0.00	3.54	8.26	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	357.65	4.08	11.09	2.33	3.50	8.75	0.00	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	437.57	7.46	10.09	1.76	4.39	5.27	0.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	321.28	5.93	11.87	5.09	6.78	6.78	2.54	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	283.53	8.36	8.36	0.60	3.58	2.98	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	386.74	12.13	8.25	2.43	1.46	4.37	0.97	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	122.12	0.00	1.14	0.00	1.14	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	143.87	3.33	2.91	1.25	1.25	0.42	0.83	0.00	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	102.33	2.25	0.00	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	130.35	3.17	2.54	0.63	4.12	0.32	1.90	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	113.21	1.67	1.67	0.84	3.76	1.67	1.25	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	409.63	13.93	17.75	14.62	1.97	3.13	2.55	4.64	1.16	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	485.64	19.07	20.26	10.97	1.86	3.38	4.39	6.75	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	491.41	17.97	14.79	13.42	2.73	2.50	3.87	5.69	1.59	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	393.62	11.81	15.08	15.41	2.19	3.83	3.17	4.59	0.98	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	460.99	19.77	17.41	12.68	1.07	2.79	3.65	6.66	1.72	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	462.21	14.42	13.13	8.61	2.58	2.37	2.15	3.01	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	376.73	10.96	15.19	15.07	3.11	3.61	2.99	5.11	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	381.36	11.67	15.44	8.92	1.54	4.29	3.77	5.15	1.54	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	421.93	17.30	14.10	7.69	2.24	4.49	4.49	4.16	0.32	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	163.41	2.80	0.56	0.56	1.12	0.00	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	100.41	0.87	0.87	0.00	0.00	0.43	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	301.39	7.93	2.64	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	174.24	5.64	2.82	0.00	1.06	1.76	0.35	0.71	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.75	0.73	0.73	0.00	0.73	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	326.25	10.49	5.59	1.57	1.75	1.40	2.27	1.22	0.17	0.17
Hepatocyte, donor1	11523-119I2	199.75	7.26	0.00	0.00	1.21	0.00	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	245.63	5.39	1.08	0.00	0.00	0.00	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	211.06	14.11	0.00	0.61	0.00	0.61	1.84	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	540.42	13.05	0.00	0.65	19.58	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	436.26	11.54	28.49	7.34	3.67	3.85	2.10	7.87	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	257.40	5.63	19.62	3.57	1.51	11.80	1.51	2.74	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	229.24	6.37	0.00	0.00	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	206.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	215.96	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	157.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	344.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	192.22	2.56	0.00	0.00	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	210.26	9.14	0.00	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	289.13	4.87	0.00	0.00	4.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	235.09	6.67	0.00	0.00	5.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	170.64	3.63	0.00	0.00	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	235.58	7.94	0.00	0.00	3.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	261.64	2.22	0.00	0.00	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	188.58	5.24	0.00	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	258.87	7.56	0.00	0.00	1.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	207.25	6.19	0.00	0.00	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	182.83	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	191.58	3.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	203.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	219.20	2.44	0.00	0.00	3.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	123.42	3.36	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	219.41	4.82	0.00	0.00	3.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	228.97	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	280.39	7.08	0.00	0.00	0.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	211.33	5.44	0.00	0.00	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	228.14	2.15	0.00	0.00	3.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	184.22	5.08	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	154.96	7.01	0.00	0.00	1.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	213.25	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	252.87	15.80	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	167.81	2.14	0.00	0.00	1.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	192.46	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	258.97	7.10	0.00	0.00	0.93	0.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	240.58	8.78	0.00	0.00	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	172.87	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	195.40	4.17	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	227.95	2.21	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	233.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	165.67	5.23	0.00	0.00	4.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	170.98	2.25	0.00	0.00	9.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	156.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	190.95	3.20	0.00	0.00	4.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	181.49	6.93	0.00	0.00	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	239.37	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	178.56	2.76	0.00	0.00	1.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	145.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	229.72	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	145.92	3.17	0.00	0.00	2.11	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	92.04	2.53	10.69	6.61	0.65	1.06	1.96	1.96	0.24	0.08
Keratinocyte - epidermal, donor2	11349-117G8	68.52	1.17	3.51	2.34	0.59	0.59	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	257.09	5.21	9.28	7.95	0.85	1.51	2.27	2.37	0.28	0.57
Keratinocyte - oral, donor1	11251-116E9	367.68	5.68	7.95	4.99	1.93	2.38	3.63	2.04	0.45	2.95
Keratocytes, donor1	11527-119I6	280.22	3.44	1.38	0.69	0.69	1.03	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	116.01	3.52	4.69	1.17	1.17	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	337.69	4.15	0.79	1.78	2.37	0.99	1.19	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	1035.22	39.56	0.00	0.00	2.20	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	276.16	5.39	10.79	3.24	5.39	9.71	2.16	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	341.84	7.15	8.07	2.31	2.19	6.92	0.92	0.23	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	375.79	10.09	15.14	3.23	1.61	13.22	1.51	1.41	0.91	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	178.34	4.98	1.42	0.59	1.90	0.47	4.03	0.24	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	135.63	2.79	0.28	0.00	1.12	0.56	2.51	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	173.78	3.78	1.42	0.31	2.52	0.79	3.94	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	141.42	5.38	0.00	0.00	1.08	0.00	3.23	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	134.58	4.10	1.26	0.00	1.26	0.95	2.21	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	121.51	3.23	0.32	0.00	0.65	0.43	2.26	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	167.44	5.75	0.00	0.00	2.05	0.41	2.87	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	89.50	2.78	0.51	0.25	0.00	0.00	1.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	125.13	3.38	0.42	0.00	1.13	0.28	2.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	171.66	1.19	1.58	1.19	1.19	0.40	3.96	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	171.20	2.33	0.58	0.78	0.97	0.58	3.30	0.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	74.61	0.93	0.00	0.19	0.37	0.19	1.11	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	162.02	5.92	0.70	0.35	1.39	0.00	2.44	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	145.26	2.39	0.72	0.00	0.95	0.72	2.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	116.20	3.16	0.55	0.14	1.51	0.27	2.33	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	175.54	2.77	0.92	0.92	1.85	0.00	3.39	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	77.00	1.25	0.00	0.31	0.62	0.62	1.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	122.05	2.56	0.73	0.37	0.55	0.18	2.20	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	168.50	3.29	0.66	0.33	1.65	0.33	2.30	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	93.43	2.34	0.59	0.29	1.76	0.29	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.86	1.99	0.25	0.25	0.50	0.75	2.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	167.31	2.42	0.97	0.48	2.42	0.97	3.39	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	185.55	2.15	0.54	0.00	0.54	1.08	4.58	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	153.50	3.33	0.91	0.30	1.51	0.76	2.57	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	149.30	3.63	0.00	0.00	1.04	0.00	1.56	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	200.81	4.61	1.26	1.05	2.72	0.42	3.56	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	133.98	3.61	0.15	0.45	0.90	0.90	2.26	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	180.91	1.38	0.00	0.00	1.38	0.69	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	160.87	5.46	0.56	0.75	1.69	0.94	2.45	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	109.00	2.01	0.53	0.32	0.64	0.21	1.70	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	172.03	5.81	0.48	0.00	1.94	0.00	2.42	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	150.84	3.64	0.66	0.66	0.99	0.33	2.32	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	107.29	2.11	0.00	0.12	0.87	0.12	1.12	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	180.66	5.18	1.85	0.74	4.44	0.74	2.22	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	146.77	2.96	1.73	0.99	0.99	0.25	1.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	110.13	2.61	0.55	0.00	1.37	0.69	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	189.77	3.22	0.96	0.00	3.22	1.61	3.86	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	193.55	5.78	0.00	0.61	1.22	0.61	2.74	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	180.70	4.62	0.70	0.28	2.94	0.28	4.20	0.56	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	183.47	3.20	0.36	0.00	2.13	0.36	3.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	109.07	1.45	0.97	0.00	0.48	0.00	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	82.01	1.40	0.16	0.31	0.93	0.00	0.62	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	165.80	4.30	0.72	0.36	0.72	0.36	2.15	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	186.53	3.59	1.96	0.33	0.33	0.33	1.31	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	67.57	0.71	0.24	0.00	0.47	0.24	1.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	210.13	5.45	0.74	0.62	0.74	0.62	2.10	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	112.95	1.54	1.02	0.51	1.02	0.77	1.02	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	161.71	4.18	0.90	0.30	1.49	1.49	3.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	274.19	9.06	9.06	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	278.47	10.74	3.07	2.30	1.53	0.00	2.30	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	259.04	13.36	2.97	2.97	2.97	0.00	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	176.87	4.23	0.85	2.12	3.81	0.85	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	273.59	14.77	1.41	1.41	5.63	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	254.04	4.67	0.93	0.00	4.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	173.13	3.09	3.09	0.52	4.12	0.00	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	197.45	5.95	3.57	1.19	1.19	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	208.55	7.24	4.52	2.71	5.43	0.23	0.90	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	273.67	7.27	5.53	3.20	2.62	0.58	0.87	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	365.99	16.21	4.05	6.75	4.05	0.90	2.70	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	259.73	7.05	4.20	3.52	4.34	0.54	0.81	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	215.17	4.11	6.16	2.57	3.08	0.00	2.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	388.14	12.35	4.59	4.59	4.59	0.71	1.76	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	345.81	9.99	6.66	4.00	4.00	2.00	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	224.64	7.13	2.04	3.06	3.57	1.02	2.55	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	416.48	15.21	4.27	6.67	4.27	1.07	2.67	0.53	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	370.14	8.88	5.67	4.72	2.83	1.32	1.32	0.94	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	202.48	3.68	7.98	2.45	6.75	0.61	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	371.02	10.60	1.63	2.45	2.45	0.00	4.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	379.63	12.91	7.08	4.79	2.92	1.25	1.67	1.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	285.59	6.45	5.04	3.08	4.20	0.56	1.96	0.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	301.89	17.52	3.09	2.06	1.03	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	371.01	9.58	6.10	5.23	5.52	0.29	2.61	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	261.86	7.47	6.88	3.59	2.69	1.20	1.20	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	434.31	11.62	6.09	2.21	2.77	0.55	1.66	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	279.61	6.36	3.89	4.24	5.30	0.35	1.06	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	241.18	7.74	6.27	3.32	4.79	0.74	1.84	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	233.71	6.91	2.30	1.15	2.30	1.15	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	267.48	8.06	3.07	2.69	3.84	0.38	0.38	0.38	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	203.24	3.40	5.66	0.00	2.83	1.13	2.83	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	318.34	6.56	4.10	4.92	4.10	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	257.12	5.87	4.52	1.81	2.71	0.00	1.81	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	216.16	6.46	3.59	1.44	2.15	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	398.10	11.95	8.22	2.24	6.72	0.75	1.49	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	271.26	10.03	3.34	4.09	1.86	1.49	2.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	283.43	6.46	4.74	3.45	3.45	0.86	1.72	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	291.14	13.70	3.43	0.86	1.71	0.00	3.43	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	314.19	8.00	4.66	3.66	2.67	0.67	0.67	1.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	249.17	4.83	4.83	4.83	4.22	0.00	1.21	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	285.82	6.40	4.27	1.42	6.40	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	281.50	8.94	4.12	3.78	2.41	0.00	0.69	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	225.97	5.90	3.22	1.61	3.76	0.00	0.54	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	280.79	10.77	4.04	2.02	2.69	0.67	2.02	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	295.22	13.33	4.82	5.56	3.70	0.00	1.11	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	302.36	12.79	1.16	0.00	4.65	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	271.84	6.35	5.29	1.06	3.17	2.12	1.06	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	270.10	8.80	4.80	2.00	2.40	0.40	0.40	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	190.44	4.36	5.09	0.73	6.54	0.00	0.00	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	269.05	5.37	4.60	3.83	3.83	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	214.58	6.91	4.44	1.48	6.91	0.49	0.99	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	198.54	3.76	3.76	2.82	1.88	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	294.65	7.54	2.01	3.02	5.53	0.00	0.50	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	239.28	4.06	3.15	1.80	5.41	0.90	1.35	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	166.95	1.72	3.44	0.00	3.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	289.03	12.02	2.67	4.01	3.56	0.89	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	247.13	5.47	5.47	1.96	2.74	0.78	1.56	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	197.26	5.94	4.62	3.96	3.96	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	270.36	8.30	2.08	2.59	3.63	1.56	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	314.61	7.88	6.13	3.50	3.50	0.00	1.31	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	229.23	7.27	1.68	1.68	1.68	1.12	1.68	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	288.83	7.51	2.65	3.09	4.42	0.44	1.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	281.96	5.01	4.63	3.09	0.77	0.77	0.39	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	230.39	6.08	4.05	1.52	3.04	0.00	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	343.16	14.42	6.25	2.88	2.40	0.00	0.00	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	271.13	13.91	3.58	2.78	3.98	0.00	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	250.34	5.47	3.65	2.43	3.04	0.00	1.82	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	211.66	8.99	2.77	6.23	2.77	0.00	1.38	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	270.93	9.88	4.18	3.80	4.18	0.38	0.76	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	239.62	9.30	3.10	1.55	0.52	0.00	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	264.23	9.07	5.44	0.60	3.02	0.00	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	298.20	9.82	5.70	4.44	2.85	0.00	0.32	0.95	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	208.97	5.33	3.73	2.13	4.26	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	222.40	6.32	1.72	0.57	4.02	0.57	1.72	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	260.20	7.71	6.17	4.11	5.14	0.51	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	244.74	4.24	3.54	2.12	5.66	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	245.72	7.94	3.97	2.27	2.27	1.70	2.27	1.13	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	254.19	6.66	4.16	4.58	3.74	1.25	0.00	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	214.55	7.05	4.70	2.35	3.92	0.00	1.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	220.05	7.10	3.34	2.51	3.34	0.42	2.51	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	239.75	8.36	5.58	3.72	1.86	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	240.86	7.36	4.68	1.34	4.68	1.34	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	322.92	10.69	2.67	2.67	4.28	0.00	1.07	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	322.47	6.47	4.45	2.42	3.64	0.81	1.21	1.21	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	241.37	4.59	0.92	0.92	1.84	0.00	0.92	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	319.19	8.89	4.45	0.89	3.56	0.00	2.67	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	334.51	13.11	4.56	4.56	2.28	1.71	0.00	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	241.57	10.74	3.83	1.53	2.30	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	333.23	14.23	6.57	3.28	2.74	1.64	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	322.50	12.03	6.24	3.12	2.23	0.89	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	315.33	11.18	4.68	3.38	3.90	0.52	1.04	1.56	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	310.33	9.95	6.63	2.65	1.33	0.66	1.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	357.52	12.47	6.24	2.08	0.00	6.24	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	73.39	1.14	0.46	0.46	0.23	0.23	14.36	0.00	0.00	1.14
Macrophage - monocyte derived, donor2	11313-117C8	91.75	4.22	1.10	0.37	0.00	0.73	5.51	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	104.73	3.28	0.92	0.92	0.39	0.26	7.73	0.13	0.00	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	80.18	3.72	10.62	5.31	0.53	2.66	1.59	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	108.54	4.91	14.58	4.44	0.79	3.01	3.96	3.64	0.16	0.79
Mallassez-derived cells, donor3	11930-125I4	144.55	4.17	20.29	5.42	1.39	2.36	4.17	4.31	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	318.86	9.67	10.96	16.44	4.68	3.19	2.59	7.07	0.80	0.90
Mammary Epithelial Cell, donor2	11350-117G9	285.50	5.79	10.71	12.16	3.47	2.61	4.34	4.63	1.74	0.87
Mammary Epithelial Cell, donor3	11422-118F9	114.74	1.50	6.49	7.73	0.25	0.25	1.25	1.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	482.01	29.83	0.00	0.00	2.71	0.00	10.85	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	354.49	8.33	0.00	0.54	1.08	0.43	11.03	0.00	0.11	0.22
Mast cell, donor2	11565-120D8	344.72	5.35	0.30	0.30	1.49	0.30	12.18	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	333.18	6.08	0.23	0.23	2.03	0.00	15.53	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	344.30	4.08	0.18	0.18	1.06	0.00	15.25	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	216.02	5.21	0.33	0.55	3.22	0.33	12.97	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	259.16	7.00	0.00	0.58	2.33	0.58	4.67	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	163.13	1.26	0.00	0.23	0.57	0.11	9.52	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	200.00	2.68	0.17	0.17	0.50	0.17	4.52	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	276.11	6.07	1.49	1.19	1.29	1.29	3.78	0.30	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	208.34	5.88	6.23	0.00	1.73	1.04	1.38	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	337.79	11.66	1.16	1.16	2.32	0.72	5.58	0.14	0.14	0.14
Melanocyte - light, donor1	11274-116H5	162.91	5.17	0.24	0.00	3.29	0.00	1.88	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	91.45	2.05	0.00	0.00	0.68	0.00	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	81.52	0.87	0.00	0.87	0.87	0.00	0.87	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	274.47	6.46	1.56	1.87	1.87	0.42	4.79	0.83	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	144.42	5.65	2.15	0.81	0.27	1.34	3.77	0.27	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	256.34	6.43	1.07	0.54	2.14	0.27	6.70	0.27	0.54	0.00
Meningeal Cells, donor1	11493-119E8	472.05	12.16	3.23	0.50	1.98	5.09	0.99	0.12	0.50	0.12
Meningeal Cells, donor2	11573-120E7	354.76	10.56	12.76	0.44	0.00	11.44	1.32	2.64	0.00	0.00
Meningeal Cells, donor3	11654-122E7	403.35	8.48	9.13	1.22	1.87	7.58	1.87	0.08	1.06	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	316.52	6.56	3.42	0.86	1.71	2.85	2.00	0.29	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	153.67	5.84	1.81	0.91	2.31	0.81	1.91	0.20	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	48.62	1.31	0.00	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	71.95	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	261.93	7.18	0.72	0.72	1.44	2.15	2.15	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	177.67	4.24	5.29	1.06	0.42	3.39	2.75	1.06	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	151.30	5.53	2.51	2.51	1.01	3.02	0.50	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	215.80	4.18	0.44	0.00	0.88	0.88	1.10	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	185.57	2.19	1.46	0.00	0.00	0.73	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	143.43	4.50	2.25	0.61	0.20	0.82	0.61	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	173.41	2.77	0.83	0.14	3.60	0.97	1.52	0.00	0.00	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	68.40	1.49	0.74	0.00	0.00	0.74	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	166.70	2.37	3.03	0.13	1.18	1.71	1.32	0.79	0.39	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	76.26	2.37	0.59	0.00	0.89	0.30	0.89	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	0.00	0.00	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	162.66	4.48	0.64	0.00	0.00	2.56	1.28	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	295.96	7.44	0.35	1.77	0.00	0.71	3.19	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	183.26	4.38	1.25	0.63	0.94	3.13	1.25	1.25	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	331.64	5.81	2.90	1.45	1.45	2.18	5.81	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	88.57	4.24	8.75	1.59	1.59	3.18	1.59	2.39	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	80.58	3.50	5.51	1.00	0.50	2.00	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	129.50	3.61	5.71	1.08	0.72	2.53	0.72	1.45	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	445.61	13.50	1.35	1.35	0.00	0.00	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.75	4.43	2.71	0.99	0.25	1.23	20.44	0.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	115.13	4.42	3.53	1.18	0.59	0.88	7.07	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	148.65	10.37	0.00	0.00	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	79.97	1.86	1.24	1.55	0.00	1.24	10.54	0.00	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	77.17	1.04	1.66	0.62	0.21	1.04	7.05	0.21	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	157.49	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	107.11	1.75	3.00	1.25	0.00	1.25	12.26	0.50	0.00	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	113.11	1.86	3.72	0.93	0.00	0.93	10.24	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	92.06	3.86	1.42	0.41	0.20	0.81	11.18	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	87.90	2.38	2.38	0.00	0.00	1.19	3.96	1.19	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	256.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	56.64	1.77	0.00	0.00	0.00	0.00	8.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	67.25	3.04	3.04	0.38	0.00	0.00	9.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	175.02	3.95	0.00	0.00	0.00	1.32	3.95	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	57.51	1.49	1.27	0.85	0.00	0.42	7.43	0.64	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	100.37	2.76	0.00	0.92	0.00	0.00	6.45	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	72.43	1.79	0.00	0.60	0.30	0.89	8.35	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	171.02	10.06	1.68	0.00	0.00	1.68	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	55.70	1.51	0.50	0.50	0.00	0.00	6.77	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	61.08	1.19	3.33	1.43	0.00	0.71	8.56	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	113.89	2.76	1.66	0.55	0.00	1.11	4.98	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	54.80	1.84	1.61	0.46	0.23	0.23	9.44	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	59.11	1.47	1.05	0.84	0.42	0.42	6.94	0.00	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	61.96	1.83	1.83	1.43	0.20	0.20	6.32	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	56.64	1.07	0.64	0.64	0.00	0.21	11.37	0.21	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	64.46	2.89	2.45	2.22	0.00	1.78	4.22	0.89	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	227.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	53.88	1.75	2.19	0.66	0.22	0.66	7.45	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	94.80	1.52	2.03	0.51	0.00	0.51	3.04	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	117.65	3.31	0.00	0.00	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	82.35	2.99	1.36	1.09	0.00	0.82	6.25	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	64.70	2.65	1.76	1.47	0.29	0.29	5.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	82.86	4.36	0.00	1.09	0.00	0.00	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	52.38	1.92	0.00	0.00	0.00	0.96	2.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	41.22	2.00	2.00	1.20	0.00	1.60	4.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	137.12	6.86	4.11	2.74	1.37	0.00	2.74	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	55.06	4.51	0.50	0.00	0.00	0.00	5.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	156.96	2.04	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	63.06	2.19	1.31	0.44	0.00	0.00	3.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	120.30	4.41	3.31	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	149.21	1.92	0.64	1.28	0.00	0.00	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	84.79	3.22	1.24	0.25	0.50	0.74	5.70	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	96.73	4.18	1.39	0.70	0.00	0.70	2.09	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	251.93	4.42	2.21	0.00	0.00	0.00	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	73.50	3.08	0.68	1.71	0.00	0.00	6.15	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	119.03	4.38	1.31	0.00	0.00	0.44	4.81	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	209.86	3.55	0.71	1.42	0.00	1.07	2.84	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	75.19	0.84	1.68	1.40	0.00	0.28	8.42	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	105.15	4.99	2.91	1.25	0.00	1.25	4.99	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	163.17	5.24	2.91	0.58	0.58	0.58	5.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	108.30	2.71	1.51	1.51	0.30	0.60	9.05	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	74.30	3.76	2.92	1.67	0.00	1.25	7.10	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	288.75	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	96.97	7.39	0.92	0.92	0.00	0.00	10.16	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	103.58	1.71	1.71	0.00	0.00	1.14	10.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	121.05	2.35	1.24	2.07	0.00	0.69	8.29	0.28	0.00	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	65.56	1.04	2.59	0.78	0.00	0.52	5.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	99.95	5.15	1.72	0.43	0.00	2.57	7.72	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	121.96	2.54	1.27	3.18	0.00	0.00	1.91	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	106.49	0.80	2.40	0.80	0.27	0.53	6.67	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	89.80	4.19	3.29	0.30	0.30	1.50	5.39	0.00	0.00	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	96.90	1.70	1.27	0.71	0.00	0.57	6.07	0.00	0.14	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	59.24	0.96	1.27	0.00	0.00	0.00	6.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	101.50	1.99	2.87	1.11	0.22	0.22	13.05	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	138.03	2.65	1.52	1.14	0.00	0.00	6.07	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	94.04	1.42	1.99	1.42	0.28	1.14	12.22	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	65.88	1.97	0.98	0.25	0.00	0.98	7.37	0.25	0.00	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	111.44	3.91	0.00	0.00	0.00	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	106.73	1.18	1.47	1.18	0.00	0.29	10.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	102.64	1.15	1.44	0.86	0.00	0.29	8.07	0.86	0.00	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	132.30	2.47	0.41	0.00	0.41	0.82	3.71	1.24	0.00	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	102.14	2.08	0.89	0.89	0.00	0.89	7.74	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	0.00	0.00	0.00	0.00	0.00	7.53	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	1.78	0.00	0.00	0.00	0.00	10.69	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	57.83	0.33	0.33	1.97	0.00	0.33	15.77	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	42.08	1.05	0.00	0.00	0.00	0.00	14.73	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	47.44	0.20	0.20	1.38	0.00	0.20	16.01	0.00	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	81.02	0.93	1.86	0.00	0.00	1.86	8.38	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	63.09	1.13	2.25	0.00	0.00	0.00	21.41	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	52.74	1.86	1.07	0.53	0.00	0.00	13.32	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	51.91	0.57	1.02	1.02	0.11	0.57	18.44	0.00	0.00	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	0.74	0.74	0.00	0.00	0.00	9.58	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.16	1.83	0.37	1.47	0.00	0.00	15.76	0.00	0.00	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	1.56	3.11	0.00	0.00	0.00	10.89	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	95.66	1.07	0.00	0.00	0.00	2.14	18.17	0.00	0.00	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	0.00	0.00	0.00	0.00	0.00	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	57.57	0.00	0.00	0.00	0.00	0.00	8.08	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	66.62	2.11	1.26	0.84	0.00	0.00	8.01	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	93.97	1.36	1.36	1.36	0.00	0.00	25.88	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	48.32	1.27	1.27	0.00	0.00	0.64	12.08	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	61.55	0.00	0.81	0.81	0.81	0.00	25.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	74.01	0.00	1.51	0.00	0.00	1.51	15.10	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	262.67	11.42	0.00	0.00	11.42	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	179.43	9.79	3.26	0.00	3.26	3.26	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	152.08	0.00	0.00	0.00	0.00	0.00	19.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	12.55	0.00	0.00	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	221.47	6.46	4.52	0.86	2.80	2.37	3.23	0.65	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	235.18	3.14	7.32	1.05	3.66	4.18	1.05	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	100.79	2.67	0.00	0.00	1.33	0.00	0.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	79.72	3.34	0.00	0.00	0.83	0.42	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	231.21	15.02	0.76	1.14	3.99	0.95	2.47	0.00	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	686.22	27.13	0.00	0.00	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	48.28	2.72	0.00	0.00	0.00	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	475.95	16.54	1.84	0.00	11.03	1.84	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	62.78	1.26	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	79.96	1.39	0.23	0.70	2.09	0.46	0.00	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	90.80	2.70	0.27	0.27	2.16	0.27	0.54	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	255.86	3.57	0.00	0.00	1.68	0.21	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	623.54	33.40	0.00	0.00	11.13	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	80.91	1.99	0.00	0.00	4.47	0.50	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	71.19	2.44	0.00	0.00	2.71	0.00	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	53.72	1.59	0.45	0.45	1.13	0.23	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	74.14	1.96	1.14	0.00	1.63	0.33	0.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	212.69	5.47	0.18	0.18	1.82	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	82.22	1.59	0.00	0.00	1.59	0.53	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	62.43	1.80	0.00	0.00	2.40	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	155.88	3.61	0.00	0.00	3.94	0.33	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.00	1.30	0.16	0.16	1.79	0.33	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	309.37	6.17	0.00	0.00	0.88	0.18	0.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	55.56	0.00	0.70	0.00	2.81	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	71.71	1.38	0.46	0.00	0.46	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	80.34	2.25	0.00	0.96	1.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	148.99	6.21	1.03	0.69	3.10	1.03	1.38	0.00	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	887.48	45.51	7.59	5.06	7.59	7.59	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	285.39	6.46	0.00	0.00	1.11	0.00	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	54.19	1.27	0.00	0.42	0.42	0.00	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	75.24	4.27	0.47	0.47	2.61	0.47	0.24	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	87.14	1.29	0.00	0.00	2.15	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	758.33	36.11	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	92.30	2.33	0.33	0.33	1.67	1.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	264.66	2.71	0.00	0.00	1.80	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	61.50	1.59	0.00	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	46.43	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	94.97	3.78	0.00	0.00	2.27	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	77.23	2.61	0.00	0.00	1.63	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	105.46	1.31	1.31	0.44	1.31	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	257.35	5.43	0.45	0.00	2.26	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	62.62	2.65	0.00	0.00	2.65	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	63.16	1.33	0.00	0.66	1.33	0.66	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	86.81	3.47	0.00	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	54.74	1.53	0.38	0.38	1.15	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	97.39	2.12	0.91	0.60	2.72	0.60	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	212.85	6.41	0.44	0.00	2.21	0.22	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	69.80	1.36	0.68	0.00	2.03	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	715.33	20.44	0.00	5.11	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	73.77	0.61	0.00	0.00	1.83	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	66.09	3.46	0.31	0.00	0.63	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	75.97	1.51	0.61	0.30	0.00	0.30	0.61	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	49.84	0.00	0.00	0.00	1.58	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	230.13	14.74	0.00	1.13	2.27	1.13	4.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	455.21	20.23	0.00	0.00	0.00	10.12	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	140.25	4.35	0.50	0.75	2.11	0.25	0.37	0.12	0.00	0.00
Myoblast, donor2	11322-117D8	243.38	7.29	0.19	0.19	4.79	0.00	0.77	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	266.71	9.75	0.50	0.00	1.51	0.17	0.00	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	427.15	12.55	0.73	1.31	3.50	0.58	7.15	0.00	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	305.98	11.69	0.00	0.00	2.46	0.00	7.07	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	243.96	11.76	0.00	0.30	1.21	0.00	4.52	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	302.22	11.04	0.00	0.55	1.29	0.00	6.44	0.18	0.00	0.00
Neural stem cells, donor1	11275-116H6	590.14	14.15	9.07	2.90	21.41	9.07	1.81	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	995.56	23.11	13.48	1.93	17.33	3.85	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	772.63	30.72	4.55	0.00	20.48	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	442.75	16.95	1.98	0.22	10.13	2.86	0.44	0.00	0.00	0.00
Neurons, donor3	11655-122E8	379.84	18.09	0.82	0.00	13.98	0.82	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	209.73	5.57	0.00	0.00	0.00	0.00	2.78	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	165.24	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	255.94	7.94	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	297.08	6.06	2.61	1.07	3.09	5.46	1.54	1.42	0.47	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	167.03	0.65	0.98	0.65	2.60	2.93	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	235.25	3.81	4.01	0.20	1.80	4.61	1.00	1.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	98.28	2.20	3.58	3.03	2.48	1.24	1.79	0.41	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	123.03	3.33	6.66	3.62	2.03	3.33	3.04	0.87	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	101.59	2.38	5.90	2.95	1.14	3.29	2.16	0.79	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	155.15	4.29	2.05	1.27	1.46	1.56	1.17	0.19	0.00	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	314.15	7.82	8.43	2.41	0.60	4.81	0.00	6.62	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	130.17	4.25	0.43	0.00	0.85	1.06	1.28	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	92.59	2.29	1.14	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	181.87	8.69	0.62	1.24	1.86	1.86	0.62	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	129.57	2.35	1.56	0.78	1.76	1.76	1.56	0.00	0.39	0.00
Osteoblast, donor2	11354-117H4	451.59	7.02	4.21	0.70	4.21	4.92	2.11	0.70	2.11	0.70
Osteoblast, donor3	11426-118G4	366.48	10.84	2.13	1.24	3.02	1.24	1.60	0.36	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	223.06	4.30	2.78	2.27	1.60	1.52	3.62	0.34	0.34	0.08
Pericytes, donor1	11491-119E6	59.75	0.89	0.56	0.00	1.00	1.22	0.45	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	88.74	2.04	0.45	0.00	1.36	0.68	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	140.99	5.29	1.02	0.00	0.41	1.02	0.41	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	275.32	3.84	5.76	0.68	1.24	5.20	1.36	0.23	0.11	0.00
Perineurial Cells, donor2	11579-120F4	276.03	10.67	4.78	1.66	2.12	3.04	3.40	0.74	0.64	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	315.87	9.24	0.00	0.96	1.91	0.32	13.07	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	158.18	3.43	0.49	0.49	0.73	0.24	5.63	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	237.61	8.28	0.00	0.65	0.91	0.00	11.91	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	154.02	2.63	1.20	0.72	0.72	0.24	0.00	0.72	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	156.35	2.22	2.22	1.11	0.00	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	167.07	3.34	0.98	0.98	0.59	0.20	0.79	1.18	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	80.70	1.58	2.85	0.32	0.00	0.00	1.58	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	87.98	2.81	2.63	0.38	0.38	1.69	1.13	0.56	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	104.94	3.26	4.57	1.17	2.87	1.96	1.96	0.78	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	127.43	3.60	4.28	1.13	0.90	2.25	0.68	0.68	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	112.85	3.41	3.30	0.85	0.21	1.07	0.43	0.85	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	125.70	4.80	3.49	0.87	0.87	4.80	1.75	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	147.83	4.58	2.86	1.29	1.00	1.29	1.72	1.00	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	86.62	0.98	0.98	0.98	0.00	0.98	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	90.60	3.69	0.92	0.31	0.92	1.23	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	358.05	10.80	1.42	1.42	2.66	1.42	3.54	0.18	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	224.61	7.15	1.70	0.85	1.53	1.19	1.87	0.17	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	312.23	9.04	4.19	1.86	3.07	2.70	2.61	0.09	0.75	0.65
Preadipocyte - visceral, donor2	11357-117H7	209.38	5.06	1.38	0.00	0.92	0.00	0.92	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	212.12	7.11	1.88	0.63	1.57	1.88	1.57	0.21	0.10	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	471.87	12.97	29.72	10.71	3.77	2.87	0.60	5.58	1.06	0.00
Prostate Epithelial Cells, donor2	11331-117E8	93.30	3.25	9.21	4.33	0.95	1.90	0.68	2.30	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	168.71	2.69	8.21	6.55	0.49	0.67	0.86	7.90	0.31	0.67
Prostate Stromal Cells, donor1	11254-116F3	254.91	7.97	7.18	2.85	2.16	2.51	1.14	1.03	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	270.38	4.84	5.02	1.08	1.43	2.87	0.54	0.54	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	171.33	5.53	3.02	0.94	0.94	1.36	1.36	1.04	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	144.53	4.01	1.82	0.00	0.36	1.09	1.09	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	173.07	2.70	3.60	2.01	1.32	1.73	1.80	1.04	0.21	0.49
Renal Epithelial Cells, donor1	11517-119H5	119.20	2.03	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	114.52	3.56	2.85	0.71	1.42	1.42	2.13	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	217.87	4.45	3.28	0.95	1.48	3.28	1.59	0.21	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	119.15	1.36	0.00	0.00	0.68	0.00	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	166.16	5.53	2.02	0.40	1.35	0.94	2.16	0.00	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	451.13	12.43	6.66	2.00	1.78	5.77	3.33	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	69.21	0.67	0.00	0.00	2.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	161.54	7.26	1.98	0.00	0.88	1.76	0.88	0.44	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	155.49	3.76	0.63	0.63	0.63	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	51.60	1.66	1.39	0.00	1.11	0.55	0.00	0.28	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	241.04	6.17	2.68	1.34	0.81	0.27	1.07	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	95.30	1.27	6.33	0.00	0.00	1.27	0.84	1.69	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	151.77	3.66	4.24	0.77	0.77	2.31	0.39	0.96	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	352.10	7.78	7.52	1.56	1.56	4.15	2.07	7.26	0.52	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	250.70	4.55	4.55	0.00	4.26	1.42	1.14	4.55	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	127.61	1.03	1.03	1.03	0.00	0.00	1.03	4.12	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	261.70	6.52	6.77	1.25	3.01	3.01	1.76	9.03	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	265.94	8.55	1.07	1.07	0.13	0.67	3.07	0.27	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	421.69	2.68	4.47	2.68	8.93	1.79	6.25	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	377.00	3.30	6.05	6.05	3.30	4.95	8.81	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	775.53	15.08	11.60	5.22	4.06	3.48	20.30	0.58	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	754.67	13.52	6.24	2.21	2.47	4.42	4.68	0.13	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	520.46	9.73	3.87	2.68	2.68	2.28	3.77	0.00	0.30	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	504.60	9.93	4.02	2.68	3.01	2.79	5.35	0.11	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	747.73	15.26	3.60	2.23	2.36	3.23	3.47	0.00	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	529.35	9.67	4.78	2.33	4.08	3.03	3.61	0.23	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	562.81	10.63	4.16	2.08	3.47	1.85	2.08	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	743.00	13.96	3.42	2.05	3.56	1.78	3.83	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	517.96	10.14	4.69	3.33	3.78	1.97	3.33	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	523.42	11.47	4.66	1.43	3.76	3.58	2.69	0.36	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	642.25	14.49	2.87	2.15	3.44	2.15	3.44	0.29	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	510.92	10.09	3.65	2.47	2.90	2.47	2.25	0.00	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	474.40	9.74	5.31	3.98	3.54	3.54	2.66	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	927.97	17.01	2.68	3.25	2.68	2.29	4.59	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	615.25	11.92	4.56	3.54	2.33	3.73	3.73	0.09	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	570.11	7.70	5.45	2.44	3.95	5.26	4.51	0.00	1.32	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	905.59	20.17	4.11	3.05	2.52	1.73	4.38	0.13	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	645.76	11.58	3.41	3.11	2.24	3.31	2.14	0.19	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	527.05	11.84	4.20	2.86	4.01	3.06	4.01	0.00	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	787.17	17.19	3.20	1.92	2.78	2.24	3.31	0.21	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	503.43	9.81	2.80	1.40	3.36	3.36	2.24	0.28	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	618.65	12.48	4.79	3.25	4.27	4.10	3.42	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	786.76	13.86	4.38	2.01	2.19	2.37	3.10	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	504.14	10.55	4.05	3.43	2.45	2.08	3.19	0.00	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	564.14	11.28	4.43	2.55	2.69	2.28	3.63	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	762.10	10.14	2.83	2.12	4.95	1.65	5.66	0.24	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	536.71	8.53	5.36	2.38	3.77	3.37	3.57	0.40	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	528.49	9.82	5.38	2.34	1.87	3.27	3.04	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	743.78	17.42	4.15	2.70	2.70	2.28	4.77	0.00	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	532.67	8.85	3.54	1.77	5.09	3.32	2.21	0.66	0.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	576.31	9.82	3.76	2.72	2.51	2.51	3.76	0.21	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	819.76	16.82	3.77	2.69	4.31	1.88	3.10	0.40	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	771.09	17.54	6.30	4.43	2.38	3.92	3.41	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	679.79	16.00	3.47	3.28	4.82	2.12	3.08	0.00	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	806.56	17.02	3.61	2.06	4.13	2.75	4.47	0.34	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	709.16	13.85	4.12	2.88	3.43	3.43	3.43	0.00	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	599.38	10.84	5.91	3.28	2.13	3.45	5.75	0.16	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	734.90	15.51	4.77	3.07	3.75	2.39	4.26	0.00	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	631.48	14.80	5.62	5.33	3.85	4.44	4.88	0.30	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	624.53	10.93	6.13	3.73	2.93	4.80	4.80	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	775.40	13.83	1.52	1.38	5.39	2.07	3.18	0.14	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	537.63	9.29	3.33	2.14	3.81	4.29	2.38	0.24	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	714.06	15.92	6.25	2.62	6.45	4.84	3.63	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	527.66	9.70	2.35	1.22	4.99	2.17	2.64	0.09	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	669.03	7.69	5.94	5.24	7.34	4.54	2.45	0.35	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	725.31	10.58	6.35	5.14	7.86	2.12	3.02	0.30	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	534.10	11.38	1.22	1.35	3.79	2.33	3.06	0.00	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	663.72	10.33	8.88	5.97	12.52	5.97	6.84	0.44	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	566.45	12.17	6.69	3.65	6.08	3.04	4.26	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	566.03	12.96	2.11	2.41	5.12	0.90	2.71	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	529.05	9.73	2.94	2.71	4.98	1.13	3.39	0.23	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	566.43	8.39	3.00	2.40	8.09	4.49	2.40	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	545.98	10.86	4.49	1.06	4.72	2.01	4.01	0.24	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	499.03	8.11	3.20	1.71	4.70	1.28	3.84	0.00	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	557.71	12.02	2.40	1.20	9.62	3.61	4.21	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	137.86	3.39	0.94	0.00	0.94	1.32	0.19	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	306.22	10.21	3.40	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	304.52	6.35	4.16	0.44	0.66	3.51	0.22	0.66	0.22	0.00
Sebocyte, donor1	11220-116B5	238.83	8.22	6.57	6.03	0.55	0.55	1.64	3.83	0.55	0.00
Sebocyte, donor2	11301-117B5	154.41	3.22	7.35	4.60	0.46	1.38	2.30	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	104.91	1.65	2.06	0.82	0.62	0.62	0.62	0.82	0.21	0.21
Sertoli Cells, donor1	11255-116F4	188.85	8.28	3.31	0.00	0.00	1.66	4.97	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	115.80	0.00	0.00	0.00	2.82	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	325.96	4.31	0.79	0.26	3.61	1.85	0.79	0.09	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	119.27	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	190.62	5.02	0.00	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	336.49	8.80	4.40	1.10	2.36	3.93	1.41	0.94	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	289.41	8.47	3.72	0.45	1.78	3.86	1.93	0.45	0.59	0.30
Skeletal Muscle Cells, donor6	11459-119B1	388.76	7.85	3.69	0.92	1.23	1.85	3.85	0.00	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	289.44	4.79	3.28	0.63	5.80	4.54	2.77	0.50	0.76	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	282.95	4.85	3.85	0.57	4.00	3.85	2.43	0.43	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	458.35	11.51	4.17	0.99	2.58	4.17	2.58	1.09	0.20	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	295.22	5.98	2.78	0.76	3.03	2.36	1.10	0.25	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	167.19	0.72	0.00	0.00	1.45	0.00	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	112.83	2.75	1.79	0.41	1.10	0.55	0.28	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	316.96	13.43	2.69	8.06	2.69	0.00	8.06	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	83.47	4.32	5.33	1.30	0.43	1.15	1.30	0.86	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	116.96	4.09	16.36	1.64	19.63	0.82	4.91	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	114.64	2.47	5.45	2.47	0.65	1.95	1.69	0.78	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	157.36	4.59	11.26	5.70	1.39	1.53	1.81	2.92	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	224.07	5.49	10.13	5.77	2.11	3.24	1.83	1.69	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	174.87	7.40	8.46	4.02	13.74	2.33	2.75	2.11	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	270.72	7.50	5.47	3.37	0.52	1.20	1.35	3.07	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	168.80	4.63	1.54	0.93	1.23	1.23	1.23	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	74.48	2.00	1.78	0.44	4.45	0.44	0.67	0.00	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	136.38	5.29	0.00	0.59	3.53	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	98.78	4.86	0.22	0.66	1.10	0.22	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	77.18	2.76	0.39	0.79	1.18	0.39	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	145.24	1.55	1.55	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	165.12	4.00	3.00	1.00	1.00	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	105.26	3.86	0.13	1.06	1.20	0.53	1.06	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	161.36	3.10	1.55	0.44	2.88	0.44	1.33	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	219.83	7.04	1.41	0.64	1.54	0.90	1.28	0.13	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	187.21	3.26	13.67	2.60	1.30	10.09	0.98	0.00	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	203.18	6.20	5.91	0.89	3.54	5.02	0.89	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	161.44	4.41	8.68	1.99	0.71	2.42	1.00	0.71	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	105.58	2.28	0.81	0.16	0.16	0.49	0.33	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	339.75	8.22	3.96	0.61	3.65	0.61	0.61	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	116.18	3.03	0.25	0.00	1.01	0.00	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	91.08	2.38	0.48	0.00	0.00	0.00	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	170.63	4.28	4.42	0.29	1.77	2.06	1.33	3.10	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	191.78	2.80	6.89	0.86	1.51	2.80	1.08	0.65	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	267.12	4.72	4.72	1.36	1.15	2.73	2.41	2.31	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	90.18	2.32	1.39	0.00	0.93	0.31	0.77	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	61.44	0.00	0.00	0.00	0.00	0.00	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	106.09	4.18	0.60	1.20	1.20	0.60	0.90	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	135.88	3.76	1.02	0.00	0.68	0.00	0.00	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	214.62	2.98	8.56	1.81	2.43	5.65	1.49	3.53	0.39	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	132.85	2.82	0.50	0.50	3.32	0.60	1.51	0.00	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	143.81	7.28	2.50	0.46	1.82	0.68	1.37	0.46	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	61.59	0.00	0.60	0.60	0.00	0.00	1.21	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	651.72	19.87	14.31	4.50	1.32	7.15	6.89	1.06	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	224.11	6.13	2.26	0.27	2.00	1.20	1.46	0.13	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	208.37	6.39	1.75	1.50	2.13	1.25	1.63	0.75	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	108.82	1.52	0.76	0.00	2.28	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	175.80	6.48	1.36	0.45	1.81	1.21	1.21	0.30	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	66.01	3.75	0.75	0.00	0.75	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	189.96	9.05	0.00	1.29	2.58	1.29	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	151.15	3.72	0.47	0.00	0.93	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	96.43	5.05	0.50	0.50	0.00	1.51	1.01	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	66.13	3.76	1.25	0.63	0.31	0.00	0.63	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	74.63	3.83	2.36	0.29	0.88	0.29	0.88	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	730.10	21.33	5.25	1.83	1.92	3.67	5.00	1.08	1.00	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	203.21	2.34	2.34	0.47	1.87	4.20	2.34	1.87	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	97.43	2.59	0.43	1.15	0.86	0.72	0.58	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	153.99	5.10	1.53	1.53	0.51	0.51	1.53	0.00	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	115.08	3.01	0.56	0.19	0.75	0.75	0.56	0.00	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	342.09	8.80	3.63	1.82	2.24	1.82	4.33	0.70	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	246.42	6.62	2.18	0.75	0.34	1.93	3.18	2.01	0.25	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	48.57	0.00	0.00	0.48	0.00	0.48	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	115.73	1.47	0.00	0.24	0.00	0.49	1.71	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	190.24	7.73	3.09	0.66	1.55	2.43	2.65	0.44	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	130.78	6.14	3.51	0.88	0.59	2.34	0.59	0.00	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	108.65	1.36	1.17	0.19	1.75	0.58	1.55	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	96.53	2.38	0.53	1.32	1.06	1.06	0.79	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	49.84	1.49	3.72	1.49	3.35	1.12	2.98	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	105.65	2.52	1.80	1.08	1.80	1.08	2.16	0.72	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	109.30	5.39	2.84	1.14	0.85	1.14	1.14	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	194.96	6.30	7.09	1.58	1.18	1.58	2.36	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	82.28	1.27	2.29	0.51	2.03	0.51	1.27	0.76	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	103.02	0.80	0.80	0.00	2.80	2.40	0.80	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	80.26	1.67	3.76	0.00	0.84	1.25	0.84	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	128.34	1.38	3.21	0.46	1.38	0.92	0.46	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	134.99	4.71	0.67	0.84	1.51	0.50	0.84	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	133.93	3.02	1.17	0.17	1.51	0.17	1.34	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	118.41	4.47	0.45	0.22	0.67	0.67	1.79	0.89	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	262.64	7.50	1.43	0.71	2.14	1.43	1.43	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	91.17	1.98	1.98	0.00	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	142.40	3.47	0.69	0.00	0.69	0.23	0.46	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	150.47	3.58	5.30	2.44	0.36	2.01	1.72	1.94	0.43	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	71.90	2.32	1.55	0.77	0.00	0.39	2.32	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	67.57	0.57	3.44	1.72	0.00	1.72	0.57	2.29	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	281.23	7.14	1.23	1.35	0.37	0.12	3.20	1.60	0.12	0.00
Urethra, donor2	10319-105A4	224.80	3.60	1.80	1.80	0.00	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	76.24	4.25	1.06	0.00	0.80	0.00	0.00	1.06	0.53	0.00
Urothelial Cells, donor2	11600-120H7	58.08	1.60	1.60	0.40	0.40	0.40	0.00	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	53.40	1.15	0.69	0.00	0.69	0.23	0.00	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	194.59	4.68	2.23	0.45	0.89	1.34	2.01	0.45	0.22	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	229.56	6.23	0.89	0.00	0.89	0.00	9.79	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	251.61	4.29	1.43	0.00	0.00	0.00	5.72	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	177.98	2.05	0.00	0.00	0.00	0.00	4.11	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	186.98	6.20	0.69	0.69	2.75	0.00	8.95	0.00	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	191.16	4.65	0.00	0.58	1.16	0.00	5.23	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	247.82	7.29	0.00	1.04	0.00	0.00	8.33	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	264.32	8.26	0.92	0.92	0.00	0.92	8.26	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	157.93	0.00	0.00	0.00	0.91	0.00	6.39	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	467.79	18.87	56.99	20.60	7.90	9.87	3.45	3.33	0.25	0.62
Wilms' tumor cell line:HFWT	10597-108E3	1012.93	23.76	0.00	0.00	3.52	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	284.90	5.59	12.01	17.88	1.68	1.12	2.79	3.91	0.28	0.56
achilles tendon, donor2	10292-104G4	84.73	0.00	0.00	2.07	0.00	4.13	6.20	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	467.08	12.24	14.79	26.26	2.04	0.51	11.22	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	797.06	19.27	13.93	12.54	8.13	2.79	11.38	0.23	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	626.18	17.57	1.31	2.02	21.96	1.90	3.56	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	772.80	29.12	0.00	0.00	6.53	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	609.67	8.71	11.52	3.09	2.53	6.46	20.24	0.56	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	395.05	7.40	1.48	1.90	3.17	1.69	13.96	0.00	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	275.75	1.36	3.81	1.63	1.09	1.09	8.17	0.54	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	513.34	6.17	8.37	1.76	0.88	2.64	7.49	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	447.15	9.80	1.63	0.41	4.08	1.63	18.78	0.41	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	406.94	8.93	5.44	7.77	6.21	4.27	12.81	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	595.24	9.38	1.66	1.84	3.31	2.02	14.72	1.29	1.29	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	265.24	3.90	7.80	0.00	3.90	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	582.58	12.32	13.48	1.39	6.51	6.51	10.46	0.00	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1022.66	19.42	8.80	3.88	3.88	6.99	25.37	0.00	1.81	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	716.58	10.52	6.14	2.34	4.09	4.97	19.58	0.00	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	387.14	6.97	0.93	1.39	2.32	1.39	12.55	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	375.47	5.76	0.00	0.82	5.35	2.06	13.98	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	271.96	6.45	0.61	0.92	0.92	0.00	3.99	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	350.75	5.12	1.28	2.13	2.13	0.85	8.53	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	386.40	6.98	0.30	0.61	4.55	0.00	7.58	0.30	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	438.32	6.26	1.68	0.96	3.13	1.20	8.42	0.00	0.96	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	447.04	6.68	1.34	0.89	2.90	1.34	9.80	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	642.41	12.67	0.00	0.00	2.33	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1715.12	33.45	3.72	0.00	7.43	5.57	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	567.63	7.91	0.75	0.00	2.26	0.75	3.77	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	878.81	16.14	0.44	0.87	13.96	0.87	2.62	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	907.24	13.12	5.62	0.00	1.87	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	289.43	10.60	7.06	3.06	0.71	1.18	2.12	3.53	0.24	2.83
adipose tissue, adult, pool1	10010-101C1	187.07	3.26	0.62	0.16	0.47	0.31	3.72	0.31	0.00	0.31
adipose, donor1	10184-103D4	581.72	12.90	19.35	28.73	17.01	3.52	4.10	0.59	0.00	0.00
adipose, donor2	10185-103D5	300.08	6.89	1.62	5.68	8.52	1.62	0.41	0.00	0.00	0.41
adipose, donor3	10186-103D6	340.36	7.35	12.25	12.53	12.80	3.27	0.54	0.00	0.00	0.00
adipose, donor4	10187-103D7	276.49	4.33	19.94	30.34	7.80	10.40	0.87	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	386.82	12.47	7.42	3.95	2.53	11.21	3.16	0.16	1.26	1.74
adrenal gland, adult, pool1	10081-102A9	80.03	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	219.45	4.14	0.13	0.27	2.53	0.13	3.60	0.00	0.00	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	375.88	13.22	3.57	1.43	7.86	1.79	1.79	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	202.87	9.74	1.62	3.71	0.00	0.00	0.46	1.16	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	335.40	10.48	0.34	0.00	1.69	0.34	1.01	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	252.18	9.13	0.00	0.88	0.29	0.59	0.88	3.54	0.29	0.59
amygdala - adult, donor10196	10167-103B5	238.35	4.74	2.37	0.00	0.00	0.00	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	381.20	9.73	0.41	0.20	0.61	1.01	2.64	0.00	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	115.55	2.90	0.97	0.97	6.46	0.32	1.94	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	473.67	5.86	0.76	1.15	2.93	0.89	2.55	0.51	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	584.21	11.47	6.18	2.65	3.31	1.10	5.07	0.66	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	538.13	24.72	5.68	0.67	17.04	6.68	1.00	2.00	0.67	6.35
aorta, adult, pool1	10052-101G7	139.84	3.53	0.39	0.20	0.20	0.98	1.57	0.39	0.00	0.00
appendix, adult	10189-103D9	352.02	9.31	4.27	3.88	1.16	0.00	5.05	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	390.71	15.48	1.38	1.03	8.25	1.72	1.38	0.00	0.34	0.00
artery, adult	10190-103E1	112.77	2.72	0.00	0.00	0.00	0.00	2.72	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	449.67	10.00	4.20	2.61	3.48	2.03	4.20	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	411.01	4.91	4.61	7.14	5.65	1.93	7.44	0.00	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	111.26	3.61	1.11	0.55	1.39	1.39	1.11	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	390.68	11.61	8.63	3.77	3.47	3.47	3.27	4.27	0.60	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	371.24	9.71	16.40	13.56	6.19	4.18	1.00	7.36	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	350.08	2.24	0.56	0.56	1.12	0.56	6.71	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	342.22	8.58	0.43	0.76	0.65	0.33	3.26	0.22	0.11	0.00
blood, adult, pool1	10053-101G8	124.02	6.64	0.00	0.00	0.00	0.00	6.64	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	440.16	11.99	0.86	0.86	2.57	0.86	0.00	0.00	0.86	0.86
bone marrow, adult	10192-103E3	211.22	6.75	2.70	0.67	4.05	1.35	7.42	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	147.61	3.08	1.03	0.00	0.00	2.05	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	255.79	3.67	0.67	0.33	0.78	0.67	1.11	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	259.13	10.69	0.00	0.00	10.69	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	787.92	27.75	22.13	16.85	8.92	2.97	3.30	0.99	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	451.73	13.36	3.74	5.62	0.87	2.37	2.25	3.37	2.00	0.62
breast, adult, donor1	10080-102A8	122.48	4.42	0.00	0.63	0.00	2.53	3.16	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	325.34	5.84	14.61	13.34	4.83	3.56	4.57	1.78	1.52	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	509.29	10.51	16.39	4.02	9.28	5.57	2.78	0.93	0.31	3.09
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	179.34	6.22	2.76	1.84	0.69	1.61	1.61	0.23	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	284.45	8.96	3.63	6.78	3.39	0.48	2.42	0.48	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	430.20	3.29	0.47	0.00	1.41	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	627.41	16.08	3.83	2.41	3.17	1.09	1.42	0.22	0.44	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	381.23	4.44	0.32	0.00	6.97	0.95	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	807.05	23.42	0.00	0.00	17.30	0.00	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	219.90	10.36	1.15	0.00	0.00	0.00	3.45	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	311.06	9.87	0.33	0.17	1.17	0.50	1.67	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	172.70	4.58	0.76	0.00	1.53	0.00	3.06	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	133.68	6.23	0.37	0.37	3.66	0.00	2.20	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	302.98	5.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	406.95	10.03	0.64	0.21	0.85	0.64	0.85	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	157.64	5.52	0.34	0.34	0.34	0.34	0.69	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	161.91	2.49	0.83	0.83	12.45	0.83	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	290.72	8.07	1.51	1.26	0.25	1.26	1.76	0.00	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	100.86	1.46	1.46	0.73	0.73	1.46	0.73	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	505.40	6.76	6.18	9.20	8.48	3.74	2.88	5.90	0.72	0.43
cervical cancer cell line:ME-180	10553-107I4	547.69	14.25	11.43	9.28	5.47	2.32	2.82	3.65	0.66	0.83
cervix, adult, pool1	10013-101C4	327.88	7.56	0.73	0.94	1.47	1.36	1.78	1.26	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	286.34	10.87	3.07	0.98	1.53	1.11	1.25	1.95	0.70	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	291.29	15.68	1.31	1.31	1.31	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	560.61	9.82	18.64	20.63	1.74	3.85	3.85	5.22	1.74	0.00
choriocarcinoma cell line:SCH	10785-110H2	210.08	4.07	14.29	30.93	1.11	1.97	1.60	5.05	0.86	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	342.96	4.74	24.19	30.36	0.71	1.42	3.08	2.37	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	128.50	7.69	1.42	4.27	0.28	0.57	1.71	0.85	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	279.60	8.05	2.68	2.88	0.40	2.29	1.99	0.40	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	169.79	4.95	1.65	2.20	0.00	0.00	1.10	1.10	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	477.64	11.11	2.02	0.00	4.04	1.01	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	413.97	12.29	4.99	0.96	1.73	3.46	12.10	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	379.08	8.45	6.12	3.38	1.69	3.80	16.47	0.21	0.21	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1209.79	17.72	0.00	0.00	6.16	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1357.18	22.49	0.00	0.00	11.85	0.00	0.00	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1256.48	24.64	0.00	0.00	6.31	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	961.40	13.84	0.00	0.00	4.71	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	634.36	9.12	3.39	1.56	4.17	2.35	16.94	0.00	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	198.64	4.11	2.74	0.69	2.51	2.29	0.46	0.46	0.46	2.06
clear cell carcinoma cell line:TEN	10636-108I6	183.05	3.99	3.99	1.04	1.74	2.60	1.04	1.04	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	411.30	10.62	40.64	26.91	3.29	9.88	0.73	5.49	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	904.97	10.26	6.08	2.28	8.36	10.64	4.18	0.38	0.38	4.56
colon, adult, donor1	10082-102B1	140.42	7.14	0.00	0.00	2.38	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	287.30	8.58	0.47	0.35	0.82	0.59	2.70	0.71	0.24	0.24
colon, fetal, donor1	10070-101I7	193.43	6.80	0.62	1.24	1.24	1.24	4.94	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	2094.67	45.84	0.00	0.00	18.33	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	375.55	0.00	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	597.88	20.40	1.27	0.42	19.12	0.42	5.10	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	567.65	20.22	1.66	1.81	10.41	0.75	8.90	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	601.98	25.52	2.12	4.23	8.32	1.41	9.59	0.00	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	385.86	11.72	0.55	0.44	2.43	1.11	2.10	0.11	0.00	0.00
cruciate ligament, donor2	10295-104G7	96.45	1.62	0.81	1.62	2.43	0.81	11.35	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	143.66	4.01	0.80	0.00	1.61	3.21	3.21	0.00	0.00	0.00
diencephalon, adult	10193-103E4	273.59	5.52	0.24	0.00	0.72	0.48	2.64	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	455.32	5.51	6.43	9.18	3.21	1.15	14.24	0.00	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	776.76	14.62	11.03	6.41	1.28	4.87	2.82	1.28	1.28	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	341.58	9.15	34.66	9.63	5.06	9.87	1.93	1.20	1.20	0.48
ductus deferens, adult	10196-103E7	231.73	9.47	1.00	0.00	1.99	1.00	1.99	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	138.26	2.88	1.44	0.00	1.44	4.32	7.20	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	301.62	5.15	1.47	1.47	5.15	1.47	3.68	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	254.04	6.03	5.12	1.90	2.15	2.73	8.67	1.49	0.74	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	313.34	10.22	4.00	1.55	30.87	0.89	0.67	0.00	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	387.32	9.89	7.16	4.16	3.15	2.72	0.29	0.14	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	783.10	18.50	9.87	4.93	3.08	3.70	0.62	0.62	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	455.58	6.96	4.24	2.42	5.45	1.82	1.51	0.61	0.30	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	798.12	17.29	16.36	6.48	6.79	5.25	2.16	0.62	1.85	1.54
embryonic pancreas cell line:2C6	10603-108E9	1359.44	24.96	17.08	7.88	2.63	6.57	1.31	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	499.44	9.72	29.16	9.72	4.36	11.73	0.34	5.36	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	368.81	11.60	1.81	1.63	4.53	1.45	0.91	0.54	0.54	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	230.45	7.40	24.60	6.59	1.13	6.11	0.00	0.80	0.48	0.64
epidermoid carcinoma cell line:A431	10426-106D3	662.51	18.67	19.34	9.23	3.00	2.45	4.11	3.11	0.89	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	503.84	11.55	19.58	18.70	2.09	3.52	6.38	12.43	1.65	0.33
epididymis, adult	10197-103E8	167.24	3.56	0.84	0.00	1.05	0.84	2.93	0.42	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	345.42	7.81	0.00	0.00	2.84	0.00	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	385.77	6.69	21.24	2.36	2.36	3.54	0.39	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	814.74	20.71	35.25	23.20	4.72	7.99	8.65	10.88	1.44	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	794.15	22.44	27.07	25.10	3.64	6.59	9.94	10.04	2.07	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	878.54	27.56	42.12	31.03	2.69	7.51	8.85	9.52	2.69	0.67
esophagus, adult, pool1	10015-101C6	280.95	9.34	0.64	1.81	0.64	0.32	2.12	0.74	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	519.35	10.90	39.83	8.89	5.51	18.53	2.00	2.25	1.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	149.70	4.83	2.41	0.00	2.41	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	107.31	2.10	0.00	0.00	0.00	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	157.75	11.91	0.00	0.00	0.00	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	151.34	3.44	0.00	3.44	0.00	1.15	3.44	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	136.99	0.00	5.83	2.91	0.00	0.00	2.91	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	229.57	3.56	1.27	0.51	0.76	1.02	2.03	1.53	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	325.69	7.82	2.56	2.18	2.44	1.54	3.72	0.38	0.13	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	329.30	11.40	1.90	1.19	0.95	3.80	0.95	0.00	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	294.14	6.76	0.09	0.09	0.84	0.28	1.03	0.09	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	585.79	14.41	15.91	9.31	5.40	2.10	6.00	9.31	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	344.90	10.33	8.32	2.93	6.22	2.93	2.56	1.01	0.27	0.00
gall bladder, adult	10198-103E9	215.60	6.04	1.45	0.97	1.21	0.48	1.93	1.45	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	350.57	10.74	0.00	0.00	5.37	0.54	5.37	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	292.44	8.96	0.00	0.75	1.87	0.00	10.08	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	373.22	8.87	9.50	6.97	2.96	2.11	2.96	1.06	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	693.98	15.67	16.44	5.61	2.32	4.45	1.93	3.48	0.58	0.19
gastric cancer cell line:AZ521	10549-107H9	664.02	21.15	5.25	2.46	11.64	4.26	1.31	0.16	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	315.75	2.75	0.00	0.00	3.66	0.00	1.83	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	409.62	11.19	2.74	1.60	6.40	1.37	1.14	0.00	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	193.11	2.18	4.36	3.44	1.03	2.87	1.61	5.51	0.69	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	414.14	5.18	24.63	6.86	4.34	10.64	1.54	2.24	0.28	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	663.20	21.45	5.74	4.99	1.50	1.25	2.00	2.24	0.25	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	602.18	19.84	3.17	0.74	8.87	2.11	0.74	0.32	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	595.32	24.72	3.79	1.97	6.32	1.83	1.12	0.00	0.56	0.00
glioblastoma cell line:T98G	10485-107A8	269.97	8.39	1.88	1.77	5.52	1.10	0.00	0.00	0.44	0.00
glioma cell line:GI-1	10413-106B8	398.02	13.77	12.89	1.76	3.51	7.03	3.51	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	200.45	3.64	0.00	0.00	1.46	0.00	2.19	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	552.39	12.69	0.98	0.24	2.20	0.49	5.61	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	143.77	5.48	0.00	0.00	1.37	0.00	4.11	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	150.82	4.26	0.53	0.53	1.60	1.07	1.60	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	2476.51	56.28	0.00	0.00	7.34	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	21.86	0.00	0.00	0.00	0.00	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	151.57	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	279.68	8.00	3.20	0.64	3.20	0.96	2.88	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	472.43	14.23	47.75	29.38	5.97	8.26	5.05	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	485.61	5.94	47.56	23.32	4.12	6.86	3.20	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	486.93	9.66	52.17	25.76	5.15	4.51	6.44	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	620.91	8.62	63.24	45.99	5.75	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	540.46	16.46	54.18	22.63	4.80	5.49	5.49	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	249.38	6.62	5.52	2.21	0.00	0.00	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	426.13	10.34	2.30	1.15	7.47	0.57	7.76	0.29	0.29	0.29
heart - mitral valve, adult	10205-103F7	214.36	4.48	1.49	0.00	0.90	0.30	1.49	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	235.07	7.32	0.52	0.00	0.78	0.52	3.40	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	635.31	36.64	0.83	0.00	3.33	0.83	3.33	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	168.55	5.31	5.31	4.69	1.22	1.63	1.22	1.63	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	119.66	4.26	0.43	0.43	0.00	0.00	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	395.10	15.64	0.23	0.00	1.15	0.23	1.61	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	445.73	14.58	0.62	0.51	0.92	0.82	2.88	0.10	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	130.51	3.70	0.62	1.23	1.85	2.47	0.93	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	1289.07	36.86	58.27	17.84	2.38	3.57	2.38	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	747.50	24.42	8.73	3.54	2.32	2.98	1.22	2.21	0.22	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	783.83	27.19	8.25	1.94	4.01	2.43	0.73	1.70	0.12	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	778.82	26.17	8.99	3.33	3.13	2.43	1.41	1.52	0.40	1.01
hepatoma cell line:Li-7	10484-107A7	464.10	10.79	13.57	4.11	0.89	4.67	0.22	1.45	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	439.59	9.75	19.90	14.47	5.83	5.33	8.14	1.11	0.50	0.90
hippocampus - adult, donor10196	10169-103B7	265.92	5.68	0.95	0.00	1.89	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	413.71	12.04	0.61	0.41	1.02	0.82	2.45	0.00	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	258.93	4.48	1.00	0.00	0.00	1.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	140.99	3.17	1.06	0.35	3.17	0.35	1.06	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	501.09	11.60	70.80	93.99	7.32	17.70	6.10	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	393.10	6.48	31.42	49.29	4.91	7.07	1.57	0.20	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	424.77	8.12	34.28	48.75	3.30	8.12	3.05	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	350.16	2.82	7.33	7.33	11.84	2.26	2.26	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	423.73	6.20	9.55	11.36	9.30	2.58	1.29	0.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	413.02	4.18	7.97	6.45	12.53	1.14	0.38	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	397.35	5.84	9.93	8.76	16.64	5.26	0.29	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	465.33	7.11	9.26	9.48	12.28	5.17	1.29	0.00	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	417.91	7.51	9.59	5.42	20.44	2.50	1.25	0.00	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	589.85	12.79	12.08	12.55	10.66	3.55	0.71	0.24	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	520.88	15.75	13.50	10.77	10.93	6.43	1.45	0.16	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	592.51	14.14	16.16	6.06	10.77	3.37	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	356.32	6.42	24.57	59.46	5.16	5.32	2.66	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	379.77	9.83	32.92	62.89	3.44	4.42	3.93	0.00	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	262.70	7.85	43.64	67.20	6.11	7.85	6.98	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	483.39	9.35	3.82	9.55	12.22	2.10	0.76	0.00	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	479.68	8.29	7.41	8.72	9.59	1.31	0.44	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	319.85	5.00	8.00	9.00	10.99	0.50	1.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	295.77	2.26	3.96	3.20	6.59	3.96	0.38	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	308.30	3.64	8.18	3.64	9.55	2.73	0.91	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	252.15	3.13	2.19	4.07	6.58	0.94	0.31	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	278.10	7.68	7.84	5.72	11.76	3.92	0.00	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	298.44	6.39	6.97	3.77	8.71	4.94	0.00	0.58	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	268.43	10.16	5.38	4.48	11.06	3.59	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	369.86	5.17	32.15	58.93	3.33	9.05	1.85	0.37	0.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	407.39	10.56	33.66	45.07	7.70	5.71	2.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	428.73	8.57	38.79	75.95	9.39	7.35	2.86	0.00	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	422.50	5.28	12.32	8.80	5.99	1.76	1.76	0.00	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	369.32	5.38	10.14	6.97	5.70	2.22	2.22	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	328.04	3.93	6.96	6.05	8.17	1.82	0.30	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	339.23	6.21	5.69	3.62	6.72	4.65	1.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	318.14	8.63	7.31	7.97	9.96	3.32	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	280.13	3.08	8.72	4.36	11.03	2.82	0.51	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	370.69	9.97	9.46	7.41	7.16	5.37	1.53	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	416.47	7.57	6.06	4.54	15.90	6.06	0.76	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	300.10	3.70	11.43	6.72	8.74	6.05	1.34	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	455.24	7.25	31.15	47.82	8.21	3.86	1.69	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	346.28	5.35	35.65	53.92	7.13	4.01	1.78	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	379.03	6.83	35.12	54.15	8.29	6.34	2.44	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	484.71	6.11	4.89	8.86	7.03	2.14	0.92	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1002.00	16.27	55.31	78.08	13.01	13.01	9.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	357.09	6.29	7.94	13.90	14.23	3.64	1.32	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	425.25	6.57	8.76	4.93	14.78	2.74	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	349.22	2.53	8.32	6.88	13.39	3.26	1.45	0.36	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	287.90	3.56	7.12	3.91	12.46	3.20	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	316.25	5.97	8.35	4.77	13.13	5.97	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	462.07	12.73	13.81	7.04	11.92	6.23	1.08	0.00	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	279.63	6.73	10.78	8.35	9.97	5.93	0.27	0.00	0.27	0.00
immature langerhans cells, donor1	11904-125F5	210.43	4.36	3.39	1.21	0.48	1.21	24.21	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	101.39	3.96	1.58	0.00	3.17	0.00	9.51	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	312.20	7.48	0.09	0.09	1.32	0.47	1.32	0.09	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	308.89	13.98	4.55	7.15	5.85	0.98	2.60	2.93	0.00	0.00
kidney, adult, pool1	10017-101C8	243.61	5.71	4.11	0.80	0.80	1.90	1.60	3.00	0.20	0.10
kidney, fetal, pool1	10045-101F9	329.06	9.12	2.33	0.50	2.19	2.62	0.99	0.85	0.28	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	856.67	24.14	9.94	1.42	10.65	11.79	6.25	0.14	0.99	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	274.69	8.02	0.97	4.01	6.77	1.11	0.55	0.00	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	641.33	10.83	9.54	9.73	2.75	2.75	4.22	2.94	0.73	0.00
left atrium, adult, donor1	10079-102A7	101.89	3.81	0.54	0.54	1.09	1.63	4.90	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	107.70	5.56	2.02	0.00	0.51	0.00	2.02	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	540.11	18.88	0.00	0.00	4.65	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	96.64	3.59	3.23	0.72	2.16	1.44	1.08	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	85.33	3.80	5.43	1.63	2.17	2.72	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	112.18	3.89	3.64	0.97	2.67	1.21	0.97	0.24	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	510.23	25.09	0.00	0.00	3.14	2.09	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	544.72	10.39	5.55	2.01	2.36	5.19	9.68	0.24	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	156.99	4.22	1.09	1.56	2.66	1.25	1.41	0.16	0.00	0.94
liposarcoma cell line:SW 872	10726-110A6	388.91	16.20	8.77	3.53	5.48	5.36	4.51	0.37	0.24	0.00
liver, adult, pool1	10018-101C9	218.94	9.24	1.13	0.65	0.16	0.49	1.30	1.46	0.16	0.00
liver, fetal, pool1	10086-102B5	57.38	1.88	0.94	0.00	0.94	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	290.34	6.85	0.73	0.29	0.58	1.31	0.73	0.00	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	309.49	6.09	0.18	0.00	0.74	0.55	1.48	0.00	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	99.03	1.41	0.28	0.00	0.28	0.85	1.41	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	184.65	4.63	0.84	0.00	1.26	1.26	4.63	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	288.14	5.67	9.00	4.43	1.11	4.84	1.25	1.25	1.25	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	519.12	28.27	4.83	5.52	2.76	2.07	0.69	8.27	0.00	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	353.14	14.63	15.42	5.14	5.67	3.69	1.58	1.05	0.00	0.53
lung, adult, pool1	10019-101D1	279.73	6.02	1.65	0.59	0.24	0.95	6.73	2.13	0.47	0.12
lung, fetal, donor1	10068-101I5	573.10	12.27	5.99	0.57	2.00	3.14	5.99	2.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	125.09	3.67	0.46	0.92	0.92	0.92	11.00	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	146.74	8.05	0.95	2.84	2.37	2.37	17.04	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	245.26	3.95	1.97	8.55	0.88	0.22	7.45	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	416.26	9.96	10.56	26.71	1.66	1.66	16.60	0.00	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	818.91	14.44	62.01	30.58	3.40	14.44	3.40	3.40	4.25	0.00
mature adipocyte, donor1	12231-129F8	234.43	6.66	0.00	0.00	0.00	0.00	0.89	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	174.12	6.23	0.00	0.00	0.42	0.21	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	156.22	4.03	0.00	0.00	0.47	0.24	0.47	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	190.04	6.32	0.00	0.26	0.53	0.00	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	813.18	19.54	18.35	24.30	6.67	4.77	1.43	0.00	0.24	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	185.00	3.38	0.00	0.00	2.26	0.00	1.13	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	332.32	8.46	0.74	0.00	0.18	0.74	2.94	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	139.78	3.18	0.00	0.00	0.32	0.32	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	167.61	3.41	2.13	1.28	2.99	0.43	2.13	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	234.23	5.91	0.34	0.17	0.68	1.35	1.52	0.17	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	392.62	9.55	0.64	0.21	0.85	0.64	2.12	0.00	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	179.14	5.78	0.00	0.00	1.93	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	430.61	43.06	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	142.14	4.67	0.00	0.00	3.23	0.36	1.79	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	170.68	3.24	3.89	0.00	0.65	1.30	4.54	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	337.47	7.28	0.31	0.00	0.93	0.46	3.56	2.94	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	294.18	7.02	0.90	0.24	1.14	0.33	2.04	0.33	0.41	0.00
medulla oblongata, newborn, donor10223	10361-105F1	162.48	4.17	1.04	0.35	2.43	1.04	2.08	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	745.27	10.85	38.53	20.59	15.06	12.40	2.44	0.89	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	448.99	10.52	0.00	0.00	2.45	0.00	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	319.55	9.92	3.88	2.16	4.02	3.31	2.30	0.29	0.57	0.00
melanoma cell line:G-361	10465-106H6	420.77	8.42	1.09	1.09	15.47	1.90	4.34	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	178.91	4.88	0.36	0.36	3.08	0.72	1.45	0.18	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	837.10	27.32	0.00	0.00	25.55	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	790.89	20.74	0.26	0.52	15.29	0.26	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	222.33	5.68	1.84	0.61	1.38	0.77	1.23	0.00	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	189.96	5.64	2.18	0.36	2.00	1.09	1.64	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	161.50	4.97	0.83	0.41	0.00	0.41	0.83	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	158.60	4.50	1.26	0.70	1.12	0.84	1.12	0.14	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	155.02	5.78	1.54	0.00	3.27	1.73	0.77	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	129.79	3.47	1.39	0.69	3.47	0.69	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	147.61	3.43	0.34	0.86	0.69	0.34	1.03	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	170.68	5.41	1.38	0.00	1.84	1.27	1.84	0.00	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	207.71	7.30	1.06	0.66	2.12	1.59	1.06	0.13	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	191.49	6.48	0.68	0.68	1.76	0.41	0.95	0.00	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	186.22	4.84	2.70	1.14	1.14	0.71	1.71	0.00	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	146.23	1.32	1.32	0.66	1.65	0.00	1.98	0.00	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	213.23	7.89	0.55	0.83	1.66	1.25	1.25	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	159.88	2.44	0.35	1.40	2.09	2.09	1.75	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	130.46	3.67	1.02	0.41	0.41	0.00	1.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	117.90	2.88	1.80	0.72	1.80	1.44	1.44	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	124.86	2.69	0.41	0.41	0.83	0.93	0.72	0.41	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	64.75	1.60	6.84	2.05	0.46	1.14	0.23	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	275.65	8.39	12.17	2.10	2.52	2.52	3.36	0.42	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	151.68	5.23	0.90	0.30	1.34	0.60	0.90	0.00	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	187.49	4.90	2.54	0.53	0.61	1.84	2.10	0.53	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	171.19	0.37	0.37	0.37	0.74	1.47	4.05	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	121.90	3.43	2.00	0.86	2.58	0.57	2.00	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	319.55	5.89	0.00	0.00	2.95	0.00	0.00	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	158.92	3.65	2.28	0.91	1.83	1.83	1.37	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	171.89	3.07	2.56	1.53	0.77	1.53	2.05	0.26	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	179.30	5.24	1.83	0.26	0.26	1.83	1.31	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	161.75	3.08	2.46	0.92	1.54	1.85	1.54	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	150.39	2.35	3.06	0.47	2.12	0.24	2.12	0.00	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	157.72	3.05	2.37	1.02	2.03	1.02	0.34	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	144.22	1.57	3.54	0.39	1.18	2.36	0.79	0.79	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	129.28	2.32	3.71	0.93	1.39	2.32	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	164.11	4.33	3.75	0.87	0.87	1.15	1.15	0.29	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	161.52	3.57	2.45	0.00	1.56	0.00	2.01	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	162.24	3.85	3.61	1.20	1.92	1.44	1.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	275.00	7.33	4.40	1.47	2.93	2.93	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	133.26	3.02	1.34	0.00	2.69	1.68	2.01	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	131.82	2.05	3.28	0.41	2.87	1.23	2.05	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	123.28	2.15	3.44	0.86	2.15	1.29	1.29	0.00	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	112.11	0.00	2.73	0.00	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	0.00	5.16	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	142.26	3.90	2.92	0.65	0.97	3.25	1.30	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	122.22	1.45	2.91	1.45	2.91	1.45	2.91	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	108.75	2.13	1.60	2.13	2.67	2.13	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	99.77	5.72	0.00	1.64	0.82	0.82	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	127.89	1.55	1.55	0.00	3.89	1.55	1.55	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	98.64	2.10	2.10	0.00	2.10	2.10	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	109.28	2.98	3.97	0.00	1.99	2.98	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	0.00	0.00	4.77	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	132.23	4.74	4.74	1.19	1.19	0.00	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	147.43	3.66	4.87	0.00	2.44	1.22	1.22	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	127.31	1.27	3.17	2.53	3.17	2.53	1.27	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	114.16	2.07	1.03	1.38	2.07	2.07	1.03	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	118.21	2.15	2.15	0.00	4.30	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	3.99	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	134.31	6.89	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	87.20	2.85	0.00	0.41	2.85	0.00	1.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	100.89	2.38	0.00	0.79	2.38	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	72.51	0.00	0.00	0.00	2.95	0.59	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	108.78	2.81	0.94	0.31	5.61	0.62	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	97.58	2.67	1.34	0.00	5.35	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	136.01	7.10	0.00	0.00	3.55	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	156.65	7.70	5.14	0.00	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	136.99	3.44	0.00	0.69	0.00	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	97.97	2.97	0.49	0.49	0.49	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	72.90	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	92.23	1.91	0.00	0.00	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	88.25	1.61	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	53.22	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	109.24	3.64	0.00	0.00	0.00	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	94.90	4.52	0.00	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	78.25	2.47	0.00	0.00	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	83.93	1.59	0.60	0.20	0.79	0.40	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	79.18	2.27	0.32	0.00	1.62	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	71.30	0.00	1.02	0.00	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	639.09	29.40	0.00	0.00	7.74	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	391.92	8.27	10.87	3.31	1.65	4.49	0.24	1.42	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	294.92	9.04	17.38	3.71	6.72	4.63	1.39	4.40	1.85	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	350.43	8.55	8.55	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	324.69	12.43	6.27	1.75	3.39	1.34	1.44	0.41	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	482.50	14.07	19.52	4.54	3.86	5.67	0.00	3.40	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	319.77	6.85	16.38	2.20	1.71	3.91	3.18	1.71	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	237.82	5.98	5.76	1.55	2.88	1.77	1.99	0.22	0.00	1.33
mesothelioma cell line:Mero-82	10853-111F7	465.69	17.87	22.34	2.89	10.51	3.42	1.05	3.15	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	329.21	11.40	4.43	1.19	5.28	1.36	4.09	1.19	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	268.45	5.81	6.57	2.78	0.76	2.27	1.52	2.27	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	232.30	5.59	20.70	2.90	3.11	3.73	1.86	2.07	0.41	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	364.76	10.77	4.80	0.83	1.66	0.66	0.50	0.17	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	292.66	10.14	20.27	5.97	3.98	6.33	4.89	4.89	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	328.49	7.00	15.37	3.42	1.02	6.32	3.76	4.44	0.68	1.54
mesothelioma cell line:NCI-H28	10845-111E8	372.28	11.96	9.67	1.53	11.45	6.87	1.02	3.82	0.51	0.25
mesothelioma cell line:No36	10857-111G2	242.04	5.22	22.18	5.87	1.96	5.55	1.30	3.91	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	390.44	11.38	7.04	1.35	5.96	2.44	2.71	3.25	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	182.71	3.45	1.34	0.38	1.34	1.15	11.13	0.00	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	170.96	3.18	0.61	1.10	0.24	0.24	9.16	0.00	0.12	0.49
migratory langerhans cells, donor3	11903-125F4	229.20	3.59	1.44	0.72	2.33	0.54	14.90	0.00	0.18	1.97
mixed mullerian tumor cell line:HTMMT	10689-109F5	349.33	4.90	5.55	1.31	0.33	1.63	1.31	1.31	0.65	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	217.66	1.91	5.09	2.97	1.27	2.76	4.03	0.64	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	578.20	22.58	34.78	22.58	1.61	5.53	2.99	3.46	0.92	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	223.40	6.28	0.19	2.28	4.38	0.38	5.71	0.00	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	630.70	13.67	3.88	3.33	5.91	4.62	10.90	0.18	0.37	0.55
myeloma cell line:PCM6	10474-106I6	270.41	5.34	0.20	3.36	5.73	0.20	3.16	0.00	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	588.96	21.81	9.13	4.57	2.54	6.59	3.04	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	296.37	11.18	0.00	0.00	2.75	0.00	0.39	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	162.35	3.01	5.46	8.91	0.33	1.11	0.89	5.46	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	140.17	1.54	5.96	7.21	0.66	0.59	0.29	3.75	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	199.82	7.18	4.42	4.42	2.21	0.55	0.55	1.66	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1081.52	26.69	6.44	1.38	29.22	23.01	0.92	0.23	1.61	0.00
neuroblastoma cell line:NB-1	10539-107G8	685.48	18.52	6.55	1.12	6.17	11.04	2.81	0.00	1.12	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	480.40	10.97	17.71	6.96	4.22	6.75	0.63	0.63	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	1626.66	30.00	5.78	1.86	33.36	10.44	1.86	0.00	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	543.48	7.59	0.00	0.00	20.64	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	397.06	11.88	31.52	5.07	6.49	28.83	0.79	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	316.18	4.03	16.91	4.83	3.02	16.70	1.81	0.00	0.60	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	970.81	20.98	45.78	6.99	3.18	52.77	0.64	0.00	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	201.75	7.19	2.66	0.80	1.60	2.40	3.73	0.00	0.53	0.27
neutrophil PMN, donor1	12133-128D9	342.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1087.28	10.32	2.71	1.35	18.43	2.20	15.22	0.00	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	355.43	8.81	4.00	0.00	2.40	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	169.28	3.85	1.28	0.96	1.60	0.96	0.96	0.00	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	156.08	5.26	6.57	1.58	3.68	3.68	0.79	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	314.78	8.34	0.28	0.09	0.84	0.94	1.31	0.09	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	249.31	6.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	474.73	14.76	0.27	0.00	1.07	0.54	1.88	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	176.88	5.46	0.73	0.00	5.46	0.00	2.18	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	209.66	6.04	0.52	0.26	1.05	0.00	1.31	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	367.74	22.31	0.86	0.00	32.18	0.86	0.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	237.16	6.15	0.24	0.08	0.63	0.16	0.32	0.00	0.00	0.00
olfactory region, adult	10195-103E6	292.12	5.92	0.76	0.00	1.15	0.76	1.91	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	322.17	4.00	0.00	2.00	2.00	2.00	2.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	420.21	14.01	17.54	12.87	5.01	2.39	0.80	6.83	0.57	1.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	631.70	6.73	14.01	8.11	5.36	4.26	1.79	2.47	0.55	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	428.05	10.50	22.69	13.88	3.56	3.56	3.05	3.89	0.85	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	792.74	21.37	6.01	1.96	4.97	2.66	2.43	0.35	0.35	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	221.95	8.23	1.76	0.88	2.35	1.47	1.47	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1198.75	35.50	5.61	1.87	0.93	3.74	2.80	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	258.92	6.15	12.30	2.12	0.64	7.63	2.12	0.21	1.27	0.00
ovary, adult, pool1	10020-101D2	366.18	9.61	1.14	0.61	0.79	1.22	3.41	0.26	0.17	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	183.87	2.93	3.30	0.92	1.28	0.73	2.57	0.18	0.00	1.65
pancreas, adult, donor1	10049-101G4	271.84	12.23	0.94	0.00	0.00	0.00	2.82	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	303.02	7.83	24.88	47.52	1.40	3.07	4.19	3.91	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	464.72	12.44	11.58	9.54	6.98	1.70	2.90	2.90	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	504.53	11.43	17.39	3.31	4.80	5.80	2.32	4.47	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	272.46	5.13	0.37	0.09	0.82	0.27	0.55	0.18	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	183.50	2.20	1.47	0.00	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	200.32	1.88	0.00	0.00	0.00	0.00	4.70	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	320.67	7.13	0.00	0.29	0.57	0.29	1.43	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	275.46	6.26	0.70	0.09	0.79	0.35	0.88	0.00	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	415.09	32.00	4.85	0.97	27.16	0.97	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	167.86	3.74	0.75	0.37	4.11	0.37	1.12	0.00	0.00	0.00
parotid gland, adult	10199-103F1	238.65	3.08	0.62	1.23	1.23	0.00	1.85	0.62	0.00	0.00
penis, adult	10200-103F2	163.82	4.83	0.00	1.07	0.54	0.00	2.69	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	386.38	5.21	4.65	1.49	9.85	3.90	0.93	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	286.58	9.18	20.98	13.70	3.93	3.79	3.93	3.50	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	353.48	7.10	2.58	3.87	2.58	1.29	3.87	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	430.54	14.21	0.59	1.78	3.55	0.00	4.15	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	227.63	7.52	1.25	0.00	1.25	1.25	3.76	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	296.46	5.06	1.01	0.00	0.00	1.01	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	379.42	8.34	0.00	0.52	2.61	0.52	2.08	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	194.93	2.55	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	276.17	8.49	1.72	1.94	0.32	0.43	1.83	0.43	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	584.27	9.80	10.20	8.34	7.02	1.99	7.81	0.40	0.66	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	225.68	9.81	0.31	0.31	2.49	0.47	0.16	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	239.87	3.79	0.26	0.17	0.77	0.26	2.07	0.00	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	224.39	3.92	0.17	0.00	0.70	0.44	1.13	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	1192.10	39.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	253.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	381.78	10.34	3.20	1.31	3.93	1.31	1.46	0.44	0.29	5.10
prostate cancer cell line:PC-3	10439-106E7	398.40	5.26	15.43	10.71	0.91	7.99	2.18	1.45	1.09	0.91
prostate, adult, pool1	10022-101D4	302.55	8.16	0.54	0.36	0.63	0.63	2.63	0.27	0.00	0.18
putamen, adult, donor10196	10176-103C5	360.23	8.50	0.71	0.71	0.71	0.47	1.65	0.00	0.24	0.00
putamen, adult, donor10252	10152-102I8	284.31	15.69	0.00	0.00	3.92	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	312.54	9.84	19.67	13.11	3.28	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	237.26	6.04	0.00	0.00	1.21	0.00	0.48	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	122.94	3.75	1.50	0.00	2.25	0.75	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	553.07	8.44	26.18	9.02	1.16	3.78	2.33	5.24	0.58	0.29
rectum, fetal, donor1	10067-101I4	275.42	11.13	2.78	0.00	12.52	2.78	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	150.09	2.54	1.06	0.21	2.97	0.85	0.85	0.42	0.00	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	189.29	0.83	0.41	0.00	1.24	0.83	2.90	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	225.64	5.37	0.70	0.50	0.80	1.09	3.18	2.39	0.30	0.10
retinoblastoma cell line:Y79	10475-106I7	322.93	4.16	8.05	8.05	1.56	8.83	1.30	0.00	1.82	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	509.25	11.68	18.57	4.55	3.44	7.87	0.98	0.25	0.12	3.07
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1118.33	18.28	12.65	2.81	1.97	16.59	1.12	0.56	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	293.29	6.06	1.52	1.52	0.00	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	192.29	6.80	9.71	8.90	8.09	2.59	1.62	5.02	0.32	0.16
salivary acinar cells, donor2	11772-123I8	156.41	5.09	6.20	7.02	12.25	0.83	1.65	4.41	0.28	0.00
salivary acinar cells, donor3	11773-123I9	309.18	13.24	3.31	3.31	1.99	0.66	0.66	3.31	0.00	0.00
salivary gland, adult, pool1	10093-102C3	235.64	8.58	0.00	0.57	1.14	1.14	3.43	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	304.53	4.55	1.43	1.69	4.05	2.11	2.95	0.00	0.67	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	321.74	4.35	1.88	1.06	2.94	2.59	3.76	0.82	0.71	0.94
seminal vesicle, adult	10201-103F3	216.39	7.94	1.06	1.06	1.59	0.53	2.65	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	325.03	19.92	11.42	3.16	3.89	1.70	1.21	1.70	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	310.51	7.55	0.50	0.25	1.26	0.25	2.01	0.00	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	440.55	3.01	1.00	1.00	0.00	0.00	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	331.10	9.13	17.46	2.01	4.84	1.88	0.27	14.78	0.54	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	405.31	7.74	4.64	7.85	2.87	1.66	1.88	2.10	0.33	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	516.62	19.61	9.03	2.32	6.32	2.32	2.32	3.48	0.39	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	114.91	3.55	0.00	0.00	0.71	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	356.33	9.00	0.00	0.24	0.36	0.24	1.32	0.00	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	147.74	1.01	3.02	1.01	2.01	0.00	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	108.56	6.79	0.00	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	186.21	5.68	1.26	0.00	2.52	3.79	3.79	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	866.16	28.35	2.67	8.00	8.34	1.00	1.00	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	738.84	24.27	3.78	0.00	23.64	2.84	0.95	0.00	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	363.71	5.20	2.70	1.16	6.55	5.78	0.39	0.19	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	1080.44	21.26	18.63	39.23	15.82	4.45	4.29	0.33	0.82	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	736.21	0.80	2.25	1.77	2.90	4.02	0.64	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	1497.75	35.74	3.05	3.27	6.76	1.74	3.27	0.22	0.65	0.22
small intestine, adult, pool1	10024-101D6	260.86	10.15	1.07	0.84	0.48	0.12	2.39	0.36	0.36	0.60
small intestine, fetal, donor1	10064-101I1	232.92	9.09	3.69	1.23	1.72	1.47	4.42	0.98	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	368.26	15.90	4.10	1.54	10.77	0.00	0.51	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	247.34	6.98	0.52	0.00	0.00	0.26	1.55	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	562.04	28.41	7.24	4.56	10.99	2.68	1.61	0.27	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	193.85	3.90	1.61	0.46	2.06	1.15	4.13	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	338.68	11.04	1.18	0.79	1.18	0.39	6.31	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	191.63	2.08	2.08	0.69	0.69	2.08	6.92	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	292.72	9.76	3.05	0.00	4.88	3.05	1.22	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	176.80	5.05	0.46	1.38	2.76	1.84	6.89	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	243.75	8.07	2.24	2.39	1.05	1.49	2.39	0.15	0.15	0.15
spleen, adult, pool1	10025-101D7	288.00	5.73	1.76	5.40	0.55	0.11	11.23	0.00	0.33	0.00
spleen, fetal, pool1	10044-101F8	298.20	8.42	1.35	1.35	0.87	1.19	5.64	0.00	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	202.57	3.83	2.69	3.31	1.45	1.97	6.42	0.10	0.31	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	507.35	10.44	7.78	6.46	6.65	2.85	2.66	1.52	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	220.50	9.44	12.93	10.83	0.00	3.49	1.75	3.49	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	466.38	14.86	11.73	4.30	5.86	2.74	3.13	3.13	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	493.01	10.13	4.28	6.75	8.44	2.25	6.64	4.50	0.34	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	241.03	5.51	0.00	0.00	2.12	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	687.49	20.73	22.85	3.81	1.27	8.46	2.96	0.85	0.42	1.27
stomach, fetal, donor1	10062-101H8	335.34	19.22	9.61	3.20	2.14	3.20	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	198.82	7.41	1.14	0.57	0.57	0.00	1.71	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	705.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	348.95	8.31	0.62	0.21	1.25	0.42	2.91	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	223.45	3.62	1.03	0.52	3.10	0.52	2.07	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	108.81	0.71	1.41	0.00	2.83	1.41	2.12	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	398.46	10.78	34.39	5.04	6.88	28.66	0.69	0.46	1.15	0.69
temporal lobe, adult, pool1	10031-101E4	228.03	5.00	0.25	0.17	0.68	0.34	0.59	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	443.03	30.63	2.85	0.00	19.94	2.14	2.14	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	494.48	14.07	0.88	0.00	24.61	0.88	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	226.57	5.93	2.44	0.70	3.14	0.70	1.40	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	156.42	3.05	0.76	0.38	4.58	0.76	0.38	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	180.51	2.97	0.00	0.37	0.74	1.11	0.37	0.00	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	560.02	11.22	12.24	49.80	3.40	1.02	2.55	0.00	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	543.22	13.10	15.72	7.71	3.85	13.10	0.92	0.77	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	478.42	8.83	14.88	48.51	3.41	3.56	1.55	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	296.17	8.00	28.94	81.75	3.43	2.41	5.08	0.13	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	737.06	6.43	18.15	23.45	2.65	3.40	3.78	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	278.87	3.49	27.70	29.56	1.31	0.65	9.27	0.44	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	359.90	6.19	17.91	29.64	5.86	0.98	6.84	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	285.61	5.05	0.43	0.54	0.86	0.43	1.83	0.21	0.00	0.00
testis, adult, pool2	10096-102C6	259.82	5.41	0.90	0.00	1.35	0.90	2.26	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	238.46	1.10	0.00	0.00	1.10	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	389.61	11.10	0.16	0.31	1.72	0.78	2.19	0.00	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	303.30	4.62	1.54	0.00	0.00	3.08	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	76.42	1.15	0.00	0.00	1.32	0.33	1.65	0.00	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	90.33	2.88	0.58	0.00	2.30	0.58	1.73	0.00	0.00	0.00
throat, adult	10209-103G2	181.51	5.49	1.00	1.50	2.25	0.25	3.00	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	248.94	10.06	3.05	0.61	3.66	1.83	3.96	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	638.72	13.12	24.84	4.17	20.67	15.50	3.58	1.19	2.78	4.97
thymus, adult, pool1	10027-101D9	811.42	40.06	0.80	0.70	3.28	1.49	2.68	0.30	0.10	0.00
thymus, fetal, pool1	10043-101F7	506.33	20.68	1.35	0.62	2.81	0.52	3.64	0.52	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	230.42	6.52	8.11	2.66	1.46	3.99	3.19	0.93	0.13	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	671.91	11.87	11.31	5.87	3.63	7.12	7.68	2.24	0.70	0.84
thyroid, adult, pool1	10028-101E1	365.51	10.17	1.31	0.37	0.19	1.31	1.96	2.52	0.37	0.00
thyroid, fetal, donor1	10060-101H6	199.59	8.70	2.64	0.26	1.85	1.05	1.05	0.53	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	166.30	15.40	3.08	0.00	0.00	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	191.88	6.05	0.23	3.95	1.40	0.00	3.02	1.40	0.93	0.23
tongue, fetal, donor1	10059-101H5	183.65	9.85	0.39	0.39	1.97	1.18	1.58	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	326.97	8.82	1.80	3.51	1.70	0.50	7.31	0.70	0.20	0.40
trachea, adult, pool1	10029-101E2	275.99	8.67	1.88	1.31	1.06	0.65	3.52	1.06	0.00	0.33
trachea, fetal, donor1	10058-101H4	221.20	8.08	4.23	1.15	2.31	2.69	1.54	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	220.71	6.73	6.02	3.19	2.13	3.19	1.42	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	754.00	15.91	13.68	5.57	8.51	3.14	3.55	6.18	0.41	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	514.56	6.11	22.09	5.64	1.57	11.28	3.13	1.25	0.78	1.57
tridermal teratoma cell line:HGRT	10694-109G1	565.05	19.03	3.81	0.00	3.81	3.81	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	331.07	11.94	16.51	5.25	5.16	7.28	1.86	1.10	0.42	0.93
umbilical cord, fetal, donor1	10057-101H3	179.44	0.00	2.09	2.09	0.00	0.00	0.00	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	352.35	12.63	0.68	0.34	2.56	1.02	1.71	0.51	0.51	0.00
uterus, fetal, donor1	10055-101H1	315.86	9.73	3.07	0.00	6.14	4.10	2.05	1.02	0.00	0.00
vagina, adult	10204-103F6	374.80	12.28	0.00	0.00	0.00	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	226.87	7.67	0.22	1.32	0.88	0.00	3.73	0.00	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	278.52	5.61	5.34	6.94	1.60	0.80	5.34	0.00	0.00	0.00